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 Axonal regeneration within the mammalian central nervous system 
following traumatic damage is limited and interventions to enable regrowth is a 
crucial goal in regenerative medicine. The nematode Caenorhabditis elegans is an 
excellent model to identify the intrinsic genetic programs that govern axonal 
regrowth. Here we demonstrate that alterations in O-linked N- beta-
acetylglucosamine (O-GlcNAc) post-translational modifications of proteins can 
increase the regenerative potential of individual neurons. O-GlcNAc are single 
monosaccharide protein modifications that occur on serines/threonines in 
nucleocytoplasmic compartments. Changes in O-GlcNAc levels serve as a sensor 
of cellular nutrients and acts in part through the insulin-signaling pathway. Loss 
of O-GlcNAc via mutation of the O-GlcNAc Transferase (OGT), the enzyme that 
adds O-GlcNAc onto target proteins, enhances regeneration by 70%. Remarkably, 
	
	 vii 
hyper-O-GlcNAcyation via mutation of the O-GlcNAcase (OGA), the enzyme 
that removes O-GlcNAc from target proteins, also enhances regeneration by 40%. 
Our results shed light on this apparent contradiction by demonstrating that O-
GlcNAc enzyme mutants differentially modulate the insulin-signaling pathway. 
OGT mutants act through AKT1 to modulate glycolysis. In contrast, OGA 
mutants act through the FOXO/DAF-16 transcription factor to improve the 
mitochondrial stress response. These findings reveal for the first time the 
importance of O-GlcNAc post-translational modifications in axon regeneration 
and provide evidence that regulation of metabolic programs can dictate the 
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The nervous system is a complex organ composed of neurons and glia that govern 
nearly every aspect of an organism’s physiology. Both conscious and unconscious 
cognitive aspects, such as thinking, controlling breathing, and movement, are intricately 
controlled by this system. Accordingly, dysfunction of this system is catastrophic and is 
exemplified by the large number of human diseases with nervous system etiologies, such 
as neuronal injury, Alzheimer’s, Parkinson’s, and Amyotrophic Lateral Sclerosis. At the 
center of all these diseases is the functional unit called the neuron, which is a highly 
specialized cell responsible for carrying and storing information and communicating in 
networks to allow functionality.  
 
1.2 Architecture and Information Flow of the Axon 
 
Neurons adapt many highly specific morphologies but contain several core 
elements vital to their function in information flow. From the polarized cell body, two 
microtubule-based structures are essential for neuronal function. The axon is a long 
microtubule projection with an actin/spectrin-based cytoskeleton for strength and 
flexibility. The microtubule direction projecting from the cell body is plus-end-out, 
meaning that the tubulin subunits are assembled in a fashion which the plus-end is 




known as synapses, with its target cell, which can be various cell types such as other 
neurons or muscle cells. Dendrites are the other microtubule-based projection extending 
from the cell body and they are generally thinner in circumference than the axon. In 
contrast to the axon, the dendrites adopt a minus-end-out conformation and the 
cytoskeleton is arranged in patches of actin with occasional spectrin lattices but not as 
highly ordered as in the axon (Stiess and Bradke, 2011). In general, the dendrites 
represent a receptive field, detecting and integrating signals whereas the axon carries 
information to other cells. Information is carried electrochemically. By altering the 
membrane potential of the neuron in the dendritic field, a threshold is reached and an 
electric wave called an action potential spreads down the axon toward the axon terminals, 
thereby controlling neuronal communication either electrically via gap junctions or 
chemically via exocytosis to affect its target cell.    
 
1.3 Caenorhabditis elegans in Neuroscience Research 
The nematode Caenorhabditis elegans (C. elegans) has emerged as a powerful 
model to study neuroscience from a single cell to a systems biology level. Established as 
a model organism in the early 1970’s by Sydney Brenner, C. elegans provides many 
advantages such as a transparent body, a fully sequenced genome, and rapid generation 
times (Brenner, 1974; Consortium, 1998). They exist predominantly in a hermaphroditic 
form and produce clonal progeny. However, a small percentage of males does exist and 
the ratio of males to hermaphrodites can be increased by altering environmental 




preyed upon by other nematode species, fungi, and pathogens (Corsi et al., 2015). The 
common laboratory strain, designated N2, was isolated from a mushroom compost pile in 
Bristol, England and is the prototype for most experiments. The typical lifespan of C. 
elegans starts as an egg and progresses through four larval stages until adulthood is 
reached roughly 46 hours after hatching at 20°C (Figure 1.1). The lifespan of C. elegans 
is dramatically affected by temperature, genetic background, and dietary influences. For 
example, the time to adulthood is only around 35 hours when grown at 25°C. In 
adulthood, C. elegans can live two to four weeks in which they are most fertile in the 
beginning week. In the absence of food, larval C. elegans in the L1/L2 stages can 
undergo an alternate lifecycle, termed dauer, in which they become thin, move less, and 
do not develop. When food is reintroduced, they revert back to their normal lifecycle. In 
contrast to their natural environment, C. elegans are cultured on an agar-based media 
which is supplemented with a lawn of Escherichia coli (E. coli). OP50 is the traditional E. 
coli strain of choice whereas RNAi experiments utilize HT115 (DE3) bacteria, due to its 
IPTG-inducible polymerase activity that is used for induction of RNAi.  
An extensive genetic toolbox is available for C. elegans research. Large-scale 
mutagenesis projects, individual laboratory genome modification, and natural population 
diversity have resulted in mutations in almost every open reading frame and most strains 
are readily available through the Caenorhabditis Genetics Center at the University of 
Minnesota (Consortium, 2012). Genes that cannot be targeted by mutagenesis can be 
knocked down with RNAi in which bacteria that produce RNAi are fed directly to the 




adoption of CRISPR/Cas9 technologies for C. elegans has allowed specific point 
mutations or other designer genome modifications to be rapidly produced (Dickinson and 
Goldstein, 2016).  The fast generation times coupled with highly accessible genetics 
allows for unprecedented in vivo forward genetic screening. These tools have elucidated 






Figure 1.1 The Lifecycle of Caenorhabditis elegans 
 
The progression from egg, through the larval stages, to the adult stages is 
detailed. This can be tracked by examining vulval development (highlighted 




The C. elegans nervous system is well-defined and highly stereotyped across 
individuals. It consists of 302 neurons and 50 glial-like cells (White et al., 1986). 
However, unlike the mammalian nervous system, these glial cells are not needed for 
myelination or trophic support. Neurons adopt a wide range of morphologies dependent 
on function ranging from the highly branched and elaborated PVD 
mechano/thermosensitive neurons that cover the majority of the body to the more 
simplistic ALM mechanosensory neurons with only a single axon extending to the head. 
In contrast to mammalian neurons, C. elegans neurons do not have spiking action 
potentials but more likely have graded regenerative potentials like plateau potentials (Liu 
et al., 2009). Whereas action potentials are stereotypical in amplitude, duration, and 
waveform, graded potentials do not display this behavior. Aside from these features, C. 
elegans neurons behave largely as neurons from other species displaying specialized 
morphologies, information conveyed by changes in membrane potential, and synapses. 
The specific set of neurons examined in this work are the touch receptor neurons, a class 
of mechanosensory neurons responsible for detecting light touch (Figure 1.2) (Chalfie 
and Sulston, 1981). There are six of these neurons classified by location in the body. The 
Anterior Lateral Microtubule (ALM) and Anterior Ventral Microtubule (AVM) neurons 
innervate the anterior side whereas the Posterior Lateral Microtubule (PLM) and the 
Posterior Ventral Microtubule (PVM) neurons innervate the posterior of the animal 
(Chalfie and Sulston, 1981; White et al., 1986). These neurons are tightly linked to the 
cuticle and upon cuticle deflection, mechanosensitve ion channels open to depolarize the 







Figure 1.2 The Mechanosensory Neurons of Caenorhabditis elegans 
 
Mechanosensory cell bodies in green have both anterior and posterior positions to 
detect light touch in the environment. The main target of the regeneration in this 
work is the ALM, which extends a single axon anteriorly and synapses within the 





(O'Hagan et al., 2005). For example, animals touched in the anterior region will reverse 
to avoid the source of the touch. In contrast to mammalian central nervous system 
neurons, C. elegans neurons can generate new growth upon injury and the regenerative 
response of the mechanosensory neurons in particular has been well-studied (Gabel et al., 
2008; Pinan-Lucarre et al., 2012). 
 
1.4 Cell Intrinsic Factors Governing Axon Regeneration 
Injury to axons or dendrites of the central nervous system is a huge public health 
burden and often devastating to the patients affected. The National Institutes of Health 
currently estimates that 1.4 million people per year are afflicted. Unfortunately, 
therapeutic prospects are limited as the central nervous system does not functionally 
regenerate. There are many hypotheses as to why regeneration does not occur ranging 
from lack of cellular competence to loss of axonal guidance cues in adulthood. Indeed, 
both cell intrinsic and extrinsic factors contribute to a regenerative response. Over a 
century ago, Santiago Ramon y Cajal, the founding father of neuroscience, agreed with 
his contemporaries like Max Bielschowsky and Walther Spielmeyer that the adult 
nervous system is fixed in nature and lacks the capacity to regenerate. Yet a detailed look 
into his drawings illustrates that some regeneration is indeed possible, albeit limited. 
Functionally, it is without question that lesions of the mammalian nervous system rarely 
regenerate fully. However, pioneering work from Albert Aguayo and colleagues in the 
1980s demonstrated that regenerative capacity relied heavily on the environment. Upon 




injured spinal cord, axon regeneration was readily observed. However, transplanting a 
piece of the optic nerve (part of the central nervous system) into the injured sciatic nerve 
resulted in little regeneration. Further work investigating the prohibitive growth 
environment of the central nervous system identified many factors that can perturb 
regeneration including myelin-associated proteins and scar tissue formation. However, 
work in the 2000s clearly demonstrated that activation of intrinsic programs can override 
environmental cues. Cultured spinal cord neurons are repulsed and avoid by myelin-
associated glycoprotein. By applying trains of action potentials, thereby increasing 
intracellular calcium and activating the calcium-dependent adenylyl cyclase, increased 
production of cAMP allowed these axons to bypass areas with inhibitive myelin signals. 
Further, administration of dibutyryl cAMP after injury can also overcome the myelin-
dependent blocks in regeneration. These studies and others highlight the importance of 
the intrinsic response to a beneficial regenerative response after injury.  
	
 Neurons injured in a post-mitotic state have to enter a growth state in order to 
regenerate. During development, the axonal growth program is up-regulated and includes 
a glycolytic metabolic profile, expression of cell-surface receptors to interpret external 
guidance cues, and various factors to promote microtubule growth. The guidance of 
axonal growth is governed by a growth cone, an actin-based structure that extends 
fillopodia to assess the external environment and decide the direction of growth (Song 
and Poo, 1999). A prominent example of this is the Slit/Robo signaling pathway in the 
developing mammalian nervous system. Developing axons express Robo-receptors at the 




the ligand source (Dickson and Gilestro, 2006). This is important in the development of 
commissural neurons to control when and where axons cross the midline, thereby 
properly connecting the two symmetrical halves of the nervous system. However, these 
guidance cues, guidance receptors, metabolic capacity, and axonal growth programs are 
lost or turned off after development thereby limiting the regenerative response during 
adulthood (He and Jin, 2016). A good example of this is the guidance and regeneration of 
the Anterior Ventral Microtubule neuron in C. elegans. During development, guidance of 
the axon to its target in the ventral nerve cord requires a dorsally-derived repulsive cue 
mediated by the Slit/Robo and TGF-beta pathways and a ventrally-derived attractive cue 
mediated by the DCC/netrin pathway. However, during adulthood, although the Slit 
signal is still expressed in the dorsal body, it is non-essential for correct guidance. 
Further, TGF-beta expression is also still present dorsally but the neurons appear to be 
unresponsive to the signal, as genetic mutants display no alterations in adulthood axon 
guidance. Regeneration of axons after injury requires the following steps: 1) membrane 
resealing 2) breakdown and cleanup of damaged cellular components 3) formation of a 
new growth cone 4) axon extension 5) re-connecting with post-synaptic targets (Figure 
1.3). C. elegans, as well as a variety of other model organisms, have provided us with 










Figure 1.3. Steps of Axon Regeneration 
1. Intact polarized neuron. 
2. Axonal injury followed by a back-propagating calcium wave and 
membrane resealing. 
3. Clearance of the damaged cellular contents and initiation of the growth 
cone 
4. Cytoskeleton polymerization, axon extension, and signaling pathways 




Through the efforts of forward genetic screening, several important pathways 
have emerged as being essential for a pro-regenerative response including calcium and 
cyclic AMP signaling, mTOR signaling, the p38 Mitogen Activated Kinase (MAPK) 
pathway, and insulin-signaling.  
 
1.4.1 Calcium/cyclic AMP Signaling: 
 
 Most studies suggest calcium acts at the initial steps of regeneration and is 
particularly important in membrane resealing and growth cone formation. After injury, a 
drastic increase in intracellular calcium is observed and a wave of calcium propagates 
back toward the cell body (Cho et al., 2015; Sun et al., 2014). The spatiotemporal 
dynamics of this increase are important for the regenerative response by acting on a 
number of distinct cellular targets. Axon damage causes an initial influx of calcium 
followed by mobilization of calcium stores in the endoplasmic reticulum (ER) and 
presumably other intracellular sinks like the mitochondria, although this hasn’t been 
thoroughly investigated (Sun et al., 2014). The temporal dynamics of this initial wave 
occurs over the span of minutes but sustained elevation of calcium levels at the site of 
injury has been observed and hypothesized to be important in the regenerative response. 
The contribution of calcium from the ER is significant (~40-50%) and is mediated 
primarily by the ryanodine receptor (unc-68). Indeed, loss-of-function mutations in the 
unc-68 gene significantly decrease the amount of calcium released and the corresponding 




levels through a gain-of-function mutation in the unc-19 voltage-gated calcium channel 
increases regenerative outgrowth (Ghosh-Roy et al., 2010). However, drastic sustained 
increases in calcium is harmful and leads to cell death as illustrated by a gain-of-function 
mutation in the mec-4 sodium/calcium channel which leads to calcium-mediated necrosis 
(Bianchi et al., 2004). It is then clear that the calcium response governs the life or death 
decision of the neuron after injury and its properly governed dynamics are crucial to 
effective regeneration. Calcium exerts its effects on regeneration through many different 
effectors either with or without the calcium-binding protein calmodulin. A well-studied 
example is the calcium/calmodulin-dependent kinases (CAMKs). Gain-of-function of the 
CAMKII (unc-43) produces a drastic decrease in regenerative outgrowth, whereas loss-
of-function mutations have no phenotype, suggesting that it is a negative regulator of 
regeneration (Chung et al., 2016). Further elucidation of the myriad of targets of calcium 
signaling is bound to uncover additional regeneration-associated genes.            
A prominent effect of calcium elevation in neurons is the activation of the enzyme 
adenylyl cyclase which generates the second messenger cyclic AMP from ATP. Indeed, 
experiments applying dibutyryl-cAMP or the adenylyl cyclase activator forskolin to 
injured axons saw an enhancement in regeneration. Further characterization in C. elegans 
revealed that cAMP elevation could significantly enhance axon regeneration in 
mechanosensory neurons (Ghosh-Roy et al., 2010). Epistasis experiments revealed that 
the effects of cAMP were downstream of calcium signaling as elevation of cAMP was 
sufficient to induce robust regeneration in the presence of an IP3-inhibitor which 




addition to cAMP did not have an additive effect on regeneration suggesting they act in a 
common pathway (Ghosh-Roy et al., 2010). As with calcium, the effects of cAMP on 
regeneration appear to act at many levels. In mammalian models, cAMP rises leads to the 
activation of protein kinase A (PKA) which in turn activates the cAMP-Response 
Element Binding (CREB) transcription factor. Activation of this pathway leads to the up-
regulation of regeneration-associated genes such as arginase I, which promotes 
polyamine synthesis and relieves the inhibition on regeneration by myelin-associated 
proteins (Cai et al., 2002; Cai et al., 1999).  
In contrast to mammals, the effect of cAMP on axon regeneration in C. elegans is 
largely independent of the CREB homolog crh-1. Instead, cAMP signaling acts on certain 
basic leucine zipper (bZip) family proteins such as cebp-1 and jun-1, although how 
cAMP transduces this signal is still unclear (Li et al., 2015). One model has been 
proposed in which the PKA homolog kin-2 phosphorylates the ETS-4 protein. Once 
phosphorylated, it can form a complex with CEBP-1 to activate target genes important in 
the initiation of the MAPK-signaling pathway  (Li et al., 2015). Thus, although an 
enhanced regenerative phenotype is observed in both mammals and C. elegans upon 
increasing cAMP signaling, the molecular mechanisms appear largely different. To what 
extent there exists a degree of overlap remains to be studied.  
 
1.4.2 PTEN/mTOR Signaling 
As developmental growth programs are often shut off in post-mitotic neurons, a 




AAV-transmitted Cre recombinase to identify neuronal growth factors involved in 
regeneration (Park et al., 2008). Of the genes tested, including p53, Smad4, Dicer, LKB1, 
and retinoblastoma (Rb), PTEN (phosphatase and tensin homolog) had the greatest effect 
on both neuronal survival and regenerative outgrowth. PTEN is an important phosphatase 
in the phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) 
signaling pathway and directly reduces PI3K activity through its phosphatase activity. 
However, in the absence of PTEN, PI3K is activated leading to the activation of the 
mTOR signaling complex and further activation of cap-dependent protein translation via 
the ribosomal S6 kinase 1 and the eukaryotic initiation factor 4E binding protein (Park et 
al., 2008). Hence the activation of this pathway leads to new protein synthesis, among 
other actions. Similar mechanisms exist in C. elegans in which mutants in the PTEN-
homolog, daf-18, can enhance axon regeneration and this effect can be blocked by 
administration of the mTOR inhibitor rapamycin (Byrne et al., 2014). Whether the 
downstream actions of mTOR are conserved in C. elegans remains unknown.  
1.4.3 The p38 and c-Jun N-Terminal Kinase (JNK) Mitogen-Activated Protein Kinase 
Pathways 
 
Mitogen-activated protein kinase (MAPK) signaling cascades are crucial for axon 
regeneration but dispensable for initial axon development (Hammarlund et al., 2009). 
MAPKs have been recognized to play an important role in mediating extracellular signals 
and stresses into injury-response programs and two specific pathways are essential for 




a mutant with spontaneous axon breaks first discovered the Dual-Leucine Zipper (DLK) 
Kinase 1, which encodes a mitogen-activated protein kinase kinase kinase (MAPKKK) 
(Hammarlund et al., 2009). Loss-of-function mutations in dlk-1 prevented regeneration 
from occurring while over-expression promoted a regenerative response. Further genetic 
epistasis experiments determined that DLK-1 activated the mitogen-activated protein 
kinase kinase (MAPKK), MAPKK4, which then acted upon the mitogen-activated 
protein kinase (MAPK), pmk-3/p38 (Nix et al., 2011). The activation of pmk-3 then leads 
to the subsequent activation of transcription factors that govern the response to injury. 
Upon injury, a combination of calcium mediated signals coupled with microtubule 
destabilization triggers DLK-1 activation, although the exact mechanisms remain unclear. 
Previous work suggests that upon an increase in cytosolic calcium, DLK-1 can change 
from an inactive heteromeric protein consisting of DLK-1 short and long isoforms to an 
active homomeric protein consisting of DLK-1 long. This then can proceed to activate the 
rest of the signaling cascade (Yan and Jin, 2012). 
In parallel to the p38 MAPK pathway, exists the c-Jun N-terminal Kinase (JNK; 
KGB-1 in C. elegans) MAPK pathway which cross-regulate one another (Nix et al., 
2011). Similar to the p38 pathway, the JNK pathway consists of a MAPKKK (MLK-1) 
signaling to a MAPKK (MEK-1) and then activating the JNK MAPK (KGB-1). At each 
step in this pathway, there exists the opportunity for cross-regulation. Exactly why this 
complex MAPK signaling is necessary for regeneration is unclear. As MAPKs respond to 
a variety of stressors, the combination of these two pathways onto convergent targets may 




these pathways is the activation of the PMK-3 and KGB-1 MAPKs. Their subsequent 
molecular actions have begun to be defined and appear to act at the transcriptional level. 
PMK-3, for example, activates the CCAATT/enhancer-binding protein CEBP-1. The 
targets of CEBP-1 are just being revealed but initial studies suggest that calcium/cAMP 
signaling triggers the formation of a CEBP-1 transcriptional complex. The transcription 
of the SVH-2 receptor tyrosine kinase is up-regulated and, upon activation by the SVH-1 
ligand, activates the JNK pathway to regulate axon regeneration (Li et al., 2015). How 
this complex pathway functions in a spatiotemporal fashion is not yet understood. 
 
1.4.4 The Insulin-Signaling Pathway 
The insulin-signaling pathway was recently identified as an important pathway in 
the age-related decline in regenerative ability (Figure 1.4). This pathway is highly 
conserved from mammals to C. elegans, although mammals have one insulin growth 
factor which binds to the insulin receptor, whereas, C. elegans have forty insulin-like 
ligands for one insulin receptor (DAF-2) (Murphy and Hu, 2013). The complexity of 
signaling of these ligands remains an active area of research but initial studies suggest 
tissue-specific expression of insulin-like ligands with both agonistic and antagonistic 
effects on DAF-2. Why C. elegans has such a large evolutionary expansion of insulin-
like ligand genes remains unknown. Once a ligand binds to the DAF-2 receptor tyrosine 
kinase, a signaling cascade is initiated ultimately resulting in the regulation of the FOXO 
transcription factor, DAF-16. Upon DAF-2 activation, the Phosphoinositide 3-kinase 




phosphatidylinositol (3,4,5)-triphosphate in the membrane. This promotes the recruitment 
of the kinase AKT-1 to the membrane for phosphorylation and activation by a variety of 
kinases including PDK and mTORC2. Activation of AKT-1 influences a number of 
downstream targets, but notable for the insulin-signaling pathway, AKT-1 phosphorylates 
DAF-16 to inhibit its transcriptional activity by promoting its nuclear exclusion (Murphy 
and Hu, 2013). Other kinases may act in parallel to AKT-1 in order to inhibit or promote 
DAF-16 activity including AKT-2 and SGK-1 (Hertweck et al., 2004; Xiao et al., 2013).  
 
The DAF-16 transcription factor regulates hundreds of genes involved in 
numerous processes including metabolism and cellular stress response. Interestingly, 
DAF-16 appears to activate tissue-specific genes, as neuronal DAF-16 targets differ 
greatly from intestinal target genes (Kaletsky et al., 2016). Further diversifying the 
actions of DAF-16, there are eight different DAF-16 isoforms produced by differential 
promoter usage, which contain different tissue expression profiles, the presence or 
absence of the DNA-binding domain, and several different N-terminal domains (Kwon et 
al., 2010). DAF-16 acts on target genes by binding to a canonical DAF-16 binding motif, 
determined in vitro to be TTGTTTAC (Furuyama et al., 2000). 
The insulin-signaling pathway and set of regulated genes is the subject of intense 
research due to the ability of DAF-2 mutants to live twice as long as wildtype C. elegans 
(Dorman et al., 1995; Kimura et al., 1997). This drastic extension of lifespan is dependent 
on the DAF-16 transcription factor and several downstream genes. In addition to aging, 




2014). Using the GABAergic motor neurons, it was found that the percentage of axons 
that regenerate in five-day old DAF-2 mutants is greater than in the wildtype, and this 
effect was dependent on DAF-16. Co-immunoprecpitation and identification of DAF-16 
targets revealed that the DLK-1 gene is regulated by DAF-16 and mutation of DLK-1 
abolishes the enhanced regeneration seen in aged DAF-2 mutants (Byrne et al., 2014). 
However, DAF-16 has hundreds of potential targets and other groups have found other 
DAF-16 target genes to influence axon regeneration, such as the forkhead-9 transcription 
factor (Kaletsky et al., 2016). Likely DAF-16 has a number of cell-intrinsic and -extrinsic 
































Figure 1.4 The Insulin Signaling Pathway and its Targets 
Insulin ligands activate the DAF-2/INSR leading to the activation of 
downstream kinases. This converges on the DAF-16/FOXO transcription 





1.5 O-GlcNAc: An evolutionarily conserved nutrient sensor 
 
In order to survive, an organism must be able to detect and respond to changes 
within its environment. Likewise, cellular assessment of fitness also occurs to govern 
important cellular decisions such as survival and growth. The mechanisms underlying the 
detection of cellular fitness are being uncovered and a number of these are nutrient 
sensors to enable the cell to optimize its metabolic response given its available resources. 
Examples of these nutrient sensors include the AMP-activated protein kinase, which 
detects levels of ATP and AMP, and the sterol regulatory-element binding protein 
pathway, which responds to changes in sterols. Glucose is an important energy source 
and its use, storage, and mobilization must be carefully monitored. O-linked beta-N-
acetylglucosamine (O-GlcNAc) post-translational modifications of serines/threonines are 
a glucose-responsive effector of proteins (Figure 1.5). The substrate, UDP-GlcNAc, is 
generated by the hexosamine biosynthetic pathway (HBP) which utilizes 2-5% of total 
cellular glucose (Marshall et al., 1991; McClain and Crook, 1996). Accordingly, O-
GlcNAc levels increase in response to increasing glucose levels and act to modify a 
plethora of proteins. In fact, O-GlcNAc is likely the most abundant protein post-
translational modification. The addition and removal of O-GlcNAc to target 
serines/threonines is catalyzed by one set of enzymes, the O-GlcNAc Transferase (OGT) 
and the O-GlcNAcase (OGA) (Hart et al., 2007). This glycosylation occurs in 
nucleocytoplasmic compartments and is different from the O-linked and N-linked 




extended. O-GlcNAc addition or removal from target proteins has complex consequences 
for protein behavior. In the simplest case, O-GlcNAc competes with phosphorylation to 
prevent protein activation. However, more complex cases suggest a dynamic interplay 
between phosphorylation and O-GlcNAcylation that has a variety of effects on protein 
conformation and behavior.  
Although O-GlcNAc modifies hundreds of proteins, alterations in O-GlcNAc 
dynamics produce distinct phenotypes which suggests there is a logical flow of 
information being transferred to alter cellular dynamics. Key pathways affected include 
the insulin-signaling pathway, calcium signaling, and the stress response, although many 
more are likely to be identified (Forsythe et al., 2006; Hanover et al., 2005; Ngoh et al., 
2011; Zachara et al., 2004). Studies of O-GlcNAc were initially deterred by the lack of 
mass spectrometry tools for detection, the lack of specific chemical inhibitors, and the 
embryonic/perinatal lethality of mutants in the mouse O-GlcNAc enzymes (Hart et al., 
2007). However, recent technological advances in all areas have allowed in depth study 
of this modification to begin. The following sections demonstrate the results of altered O-








Figure 1.5 Schematic detailing O-GlcNAc Addition and Removal on 
Proteins 
 
The O-GlcNAc Transferase recognizes proteins using its tetratricopeptide 
repeat domain and adds the O-GlcNAc moiety to target 
serines/threonines. The  O-GlcNAcase is a specific hydrolase that 






1.5.1 Human SNPs in the O-GlcNAc Transferase and O-GlcNAcase Genes: 
 
Single nucleotide polymorphisms in the OGT and OGA genes have been 
associated with human disease. The OGT enzyme has N-terminal tetratricopeptide 
repeats (TPR) used to interact with target substrates and a C-terminal catalytic domain. 
Hemizygous polymorphisms in the TPR region have been associated with X-linked 
Intellectual Disability (Vaidyanathan et al., 2017; Willems et al., 2017). The first 
mutation leads to aberrant splicing of the target mRNA and no protein is translated. The 
second is a missense mutation which changes arginine 284 to a proline results in an 
enzyme with decreased protein stability and reduced substrate glycosylation in HEK293T 
cell lysates, although global O-GlcNAc levels in patient-derived fibroblasts remain 
unaffected (Willems et al., 2017). As the mutation is located in the substrate recognition 
domain, it is possible that only certain OGT substrate interactions are affected and this 
might not be detected when looking at global O-GlcNAc levels. Alternatively, OGT in 
mammals has a second catalytic function which cleaves the transcriptional co-regulator 
Host Cell Factor 1 (HCF1) producing N-and-C-terminal subunits that regulate different 
cellular activities. HCF1 is another gene also associated with X-linked Intellectual 
Disability and the catalysis was affected in patient-derived fibroblasts (Willems et al., 
2017). Whether OGT is important as a glycosyltransferase, a protease, or both in X-





SNPs in the OGA gene have also been identified. A survey to identify SNPs 
associated with type II diabetes in Mexican Americans, identified a SNP localized to 
intron 10 that lead to a 2.27 times increased risk in developing diabetes and a significant 
decrease in the age of onset (Lehman et al., 2005). Interestingly, the risk was conferred in 
the heterozygous state and no homozygous subjects were found. While detailed 
molecular studies of this SNP have not been performed, intron 10 contains an alternative 
stop codon, which may suggest its involvement in differential expression of various 
isoforms of OGA/MGEA5.  
 
1.5.2 Disruption of O-GlcNAc Signaling in Mouse Models: 
 
As mentioned above, deletion of OGT is perinatal lethal in mice but a 
combination of different promoters driving tissue-specific expression have begun to 
elucidate the role of OGT in cellular functions (Shafi et al., 2000). O-GlcNAc appears to 
be particularly important in the neurons of the central nervous system as mutation of 
OGT in all neurons using the synapsin-I-Cre and a floxed OGT allele results in lethality 
by postnatal day 10 (O'Donnell et al., 2004). However, by using more targeted Cre 
promoters, such as alpha-CaMKII, disrupting OGT results in adult obesity (Lagerlof et 
al., 2016). This is caused by a reduction in excitatory synaptic activity in neurons of the 
paraventricular nucleus of the hypothalamus. Without this activity, the signal to cease 
feeding is not transmitted and hyperphagia occurs (Lagerlof et al., 2016). In addition, O-




(CREB) is heavily modified by O-GlcNAc in an activity-dependent manner. The addition 
of O-GlcNAc to CREB suppresses its transcriptional activity by reducing its ability to 
bind with an important coactivator. Without binding to the CRTC-coactivator, CREB 
cannot sufficiently induce gene transcription and initiate memory formation(Rexach et 
al., 2012).  
 
Deletion of OGA in mice also results in perinatal lethality (Keembiyehetty et al., 
2015). This phenotype was associated with severe hypoglycemia. Analysis of the liver 
revealed that there was a reduction in glycogen stores suggesting that glucose 
homeostasis is disrupted. The respiratory exchange ratio is the ratio of the amount of CO2 
produced to the amount of O2 consumed. Ratios of 0.70 are indicative of oxidative lipid 
metabolism and ratios closer to 1.00 suggest carbohydrate metabolism, as oxidative lipid 
metabolism consumes more O2. Heterozygous OGA mutants display a clear preference 
toward carbohydrate metabolism. This suggests that OGA mutants prefer to utilize 
carbohydrates as a substrate for metabolic processes and that this shunt toward 
carbohydrate use is not sustainable and eventually leads to lethality (Keembiyehetty et 
al., 2015). Using a nestin-Cre targeted to all neurons revealed important functions for 
OGA in the brain (Olivier-Van Stichelen et al., 2017). While OGA brain-conditional 
knockouts were viable, fertile, and had similar longevity to wildtype controls, they had a 
reduction of size in certain brain regions such as the olfactory bulb and the anterior 
pituitary. In addition, these mice exhibited fatty liver syndrome and 50% higher body fat 




this remains to be tested (Olivier-Van Stichelen et al., 2017). Accordingly, circulating 
levels of adiponectin and insulin were increased while IGF levels were decreased. 
Interestingly, OGA brain-conditional knockouts displayed a massive increase in cellular 
proliferation in the brain but altered neurogenesis. The resulting neuronal/cellular 
phenotype is quite complex and requires further study using neuronal-population specific 
knockouts.  
 
1.5.3 Disruption of O-GlcNAc Signaling in Caenorhabditis elegans Models: 
 
 In contrast to mice, mutation of OGT or OGA is well-tolerated in C. elegans 
although OGT and OGA mutants live slightly shorter and longer lives, respectively (Love 
et al., 2010). As in mice, similar effects on body fat and sugar content are observed, but 
curiously, disruption of OGT or OGA produces similar results with less triglyceride 
storage but more glycogen storage (Forsythe et al., 2006). This is hypothesized to be due 
to the increase in inhibitory GSK-3b phosphorylation leading to a release on glycogen 
synthase and increase in glycogen formation and storage (Forsythe et al., 2006). It is 
somewhat paradoxical that both OGT and OGA mutants display similar organismal 
metabolic phenotypes and exhibit similar effects on GSK-3b phosphorylation, especially 






 O-GlcNAc mutant C. elegans also display an altered stress response. OGT 
mutants are more susceptible to heat and toxic exposures while OGA mutants are 
resistant (Love et al., 2010; Rahman et al., 2010). At the neuronal level, O-GlcNAc also 
appears to serve a neuroprotective role, although in the opposite direction. The 
introduction of various human neurodegenerative alleles produces neurodegeneration in 
C. elegans resulting from tauopathy, polyglutamine expansion, or amyloid aggregation 
(Wang et al., 2012). Loss of OGT appears neuroprotective whereas loss of OGA appears 
to exacerbate the neurodegeneration. For example, introducing the Htn-Q150 allele, 
which has the human huntingtin protein and a tract of 150 glutamine residues, in a subset 
of amphid neurons results in neurodegeneration of ASH neurons. At day eight of 
adulthood, 59.4% of neurons were degenerating and 8.9% were dead in wildtype animals 
whereas OGT mutants had 10.4% degenerating and 0% dead and OGA mutants had 
35.9% degenerating and 51.3% dead (Wang et al., 2012). The examples provided above 
illustrate that while O-GlcNAc modifies many diverse proteins, the resulting phenotypes 
after modification are quite specific and therefore it is likely that specific pathways are 
affected. It is likely that the lack of cell-specific manipulations of O-GlcNAc levels have 
led to differing conclusions in C. elegans studies. Organismal effects on metabolism or 
growth rates could be leading to non-intrinsic effects.  
 
1.6 Goal of this Dissertation: 
 The multitude of effects O-GlcNAc exerts on neuronal physiology, metabolism, 




influence axon regeneration. When the research for this dissertation began, the 
knowledge of the role of O-GlcNAc in neurons was limited. Axonal growth in cultured 
embryonic neurons was significantly affected by O-GlcNAc modulation but the 
underlying mechanism remained elusive. In embryonic chicken forebrain neurons, over-
expression of the O-GlcNAcase and, therefore, a reduction of O-GlcNAc levels increased 
axon length primarily by affecting branching and corresponding branch length. Likewise, 
knocking out the O-GlcNAc Transferase in developing mouse neurons in culture resulted 
in enhanced axon length, whereas over-expressing OGT reduced axon growth. A CREB 
siRNA abolished the effects suggesting O-GlcNAc was modifying CREB to influence 
axon length. Further, one study suggested that the O-GlcNAc levels are enhanced in the 
growth cone of developing axons suggesting its importance in this specialized structure. 
These studies and others compelled us to examine the effects of O-GlcNAc on axon 
regeneration.  
 
The goal of this dissertation is to 1.) determine whether O-GlcNAc signaling 
influences axon regeneration, 2.) determine mechanistically how this is achieved, and 3.) 






Gene Organism Type of Lesion Phenotypes References 
OGT         
  Homo sapiens SNP 
X-linked intellectual disability 
and developmental delay; 
craniofacial alterations 
Willems et al., 
2017; 
Vaidyanathan 
et al., 2017 
  Mus musculus 
Cre-mediated Whole 
Organism Knockout perinatal lethal 
Shafi et al., 
2000 
    
Cre-mediated Neuron 
Knockout lethality at postnatal day 10 
O'Donnell et 
al., 2004 
    
Cre-mediated 
Paraventricular 
Nucleus of the 
Hypothalamus 
Knockout 
obesity and hyperphagia; 






elegans Large-scale deletion 
decreased lifespan, increased 
glycogen, decreased 
triacylglycerols, inhibits dauer 
formation, sensitive to heat-
stress, neuroprotective  
Forsynthe et 
al., 2006; Love 
et al., 2010; 
Rahman et al., 
2010; Wang et 
al., 2012 
          
OGA         
  Homo sapiens SNP 
Increased risk of developing 
diabetes in Mexican-Americans 
Lehman et al., 
2005 
  Mus musculus 
Cre-mediated Whole 
Organism Knockout 
neonatal lethality associated with 
reduced glycogen levels and 
hypoglycemia 
Keembiyehetty 
et al., 2015 
    
Cre-mediated Neuron 
Knockout 
developmental delay, increased 
cellular proliferation, altered 
neurogenesis and differentiation, 
obesity with fatty liver 
syndrome, decreased circulating 
free fatty acids, increased 
circulating triacylglycerides, 
increased circulating insulin, 






elegans Large-scale deletion 
increased longevity, increased 
glycogen, decreased 
triacylglycerols, promotes dauer 




al., 2006; Love 
et al., 2010; 
Rahman et al., 
2010; Wang et 
al., 2012 







2.1 C. elegans strains and culture 
All strains were cultured and maintained at 20°C on Nematode Growth Media 
agar plates [3g NaCl, 22g bactoagar, 2.5g bactopeptone, 1mL of 5mg/mL cholesterol in 
100% ethanol, 1mL of 1M CaCl2, 1mL of 1M Mg2SO4, 25mL of 1M KPO4, 975 mL of 
H2O] seeded with OP50 E. coli, except in RNAi experiments as noted. Strains were 
obtained from the Caenorhabditis Genetics Consortium (CGC at the University of 
Missouri) and the National Bioresource Project (NBRP; Japan). Select strains in this 
work were gifts from Monica Driscoll (PTN73), Rik Korswagen (KN131), and Michael 
Nonet (NM2637). To visualize the mechanosensory neurons (ALM & PLM neurons), 
strains were crossed into either SK4005 (zdis5 [pmec4::GFP]) or KWN177 [pmec-
4::mCherry; unc-119+] background. A full list of all strains and sample sizes is provided 
in Appendix 1.  
 
The generation of males for crossing between strains was conducted by taking 30 
L4 hermaphrodite nematodes and heatshocking them at 25°C for 5-6 hours, then 
returning them to 20°C. Males in the next generation were searched for, picked out, and 





2.2 Axon Regeneration Assay with an Infrared Femtosecond Laser 
 To induce a highly local, specific, and reproducible axonal injury in 
Caenorhabditis elegans, a Coherant Mantis infrared laser was used. In this system, a 
sapphire crystal doped with titanium is excited by a green pump laser to emit a mode-
locked pulsed, infrared wave beam. An optoacoustic pulse picker generates a 10 kHz 
train of 100 femtosecond pulses, which is then guided into the back of an inverted 
microscope. Using a high NA objective (such as the 60X NA 1.4 used in this work), 
allows for high spatial resolution of the beam. The use of an infrared beam with a 
wavelength spread around 800nm is used for tissue penetration, as tissue at these 
wavelengths is almost transparent. Using a pulsed beam, as compared to continuous, 
leads to higher peak energies for a given laser power. Further, the pulses are spaced in 
time so that energy between each pulse dissipates and does not lead to excess tissue 
damage (Gabel, 2008).  
Single nematodes were placed on a stiff agarose pad composed of 8% agarose in 
Nematode Growth Buffer (NGM), which is fixed on a glass slide. A 2:1 ratio of 0.05 
micron polystyrene microspheres (PolySciences Inc.):NGM buffer was spread across the 
pad and individual nematodes were picked onto the pad. A glass coverslip was gently 
placed over the nematodes in solution and the coverslip was fixed in place with a 1:1 
ratio of paraffin and petroleum jelly. Done correctly, animals were completely 
immobilized without chemical treatment (Kim et al., 2013). In total, the laser surgery to 
rescue took < 15 minutes.  After being mounted on the slide, the nematodes were 




performed with a Nikon 60X NA 1.4 oil objective. Axons of the Anterior Lateral 
Microtubule (ALM) and Posterior Lateral Microtubule (PLM) neurons were severed at 
20µM and 40µM from the neuronal cell body, producing a 20µM gap. A 10-kHz train of 
100 femtosecond pulses in the near infrared (800 nm) with pulse energies of 15-30 
nJ/pulse, was generated and axotomy consisted of 3-5 short laser exposures (0.25s each) 
resulting in vaporization at the focal point and severing of the targeted axon. After 
surgery, nematodes were rescued by removing the coverslip, placing them in fresh NGM 
buffer, and moving them to a new NGM agar plate to recover. Regeneration was 
analyzed by placing nematodes on a 2% agarose pad containing 5mM sodium azide for 
immobilization. Z-stacks of the regrowth were imaged with a Nikon 40X NA 1.3 oil 
objective at the designated time point. Time points analyzed in this work were 1, 3, 5, 12, 
and 24 hours after injury. For the 1-hour, 3-hour, and 5-hour time points, animals were 
maintained on the slide and desiccation was prevented by sealing the slide in paraffin 
wax. For the 12-hour, 24-hour, and 48-hour time points, animals were rescued with NGM 
buffer after axotomy and placed on NGM agar plates seeded with OP50 until reimaging.  
A maximum intensity projection of the Z-Stack was produced with ImageJ/FIJI Imaging 
Software and regeneration was measured by tracing the new outgrowth. It is worth noting 
that this approach loses information in the Z-direction but we have not found it to affect 








Figure 2.1 Schematic of the Laser Axotomy Protocol 
 
Left: Generation of infrared pulsed laser is by pumping a Ti:Sapphire crystal 
with a green laser. Once the infrared beam is generated, it is shunted to a 
pulse picker. This is then diverted into the microscope. 
 
Right (Top): C. elegans are immobilized with polystyrene beads and affixed 
to a glass slide. 
 
Right (Bottom): A sandwich slide is made in which a 10% agarose pad with a 
slurry of polystyrene beads is placed on a glass slide. C. elegans are placed in 
the bead slurry and a coverslip is placed on top. The coverslip is held in place 






2.3 Filopodial Dynamics: 
 
 Filopodia were quantified at 1-hour, 3-hour, and 5-hour time points and imaged 
on a Nikon inverted microscope at 60X, as detailed above. Filopodia were defined as 
novel finger-like growths appearing from either the cell body or the cut site. The first 
appearance of novel filopodia was recorded at 1 or 3 hours post-injury and quantified. 
Filopodia were counted at 1, 3, and 5 hours post-injury and dynamics were analyzed over 
time. 
 
2.4 Drug Treatments in C. elegans 
 
For all drug treatments, the drug was dissolved in NGM agar plates and animals 
were cultured on them for 24 hours before and 24 hours after injury. Thiamet G (Cayman 
Chemical), to inhibit the O-GlcNAcase was dissolved in 100% EtOH and used at a 
concentration of 2µM. ST045849 (TimTec), to inhibit the O-GlcNAc Transferase, was 
dissolved in DMSO and used at a concentration of 50µM. Rapamycin (LC Laboratories), 
to inhibit mTOR, was dissolved in DMSO and used at a concentration of 100µM, as in 
Byrne et al., 2014. Glucose (Sigma) at 1, 10, and 100mM and phloretin at 1mM (Cayman 
Chemical), to inhibit glucose transporters, were dissolved in NGM Buffer. 2-deoxy-D-
glucose (DOG) was dissolved in NGM buffer and used at a concentration of 5 and 





2.5 In vivo Calcium Imaging: 
 
Calcium imaging was conducted by using C. elegans with the calcium-responsive 
genetically-encoded indicator GCaMP3 expressed specifically in the mechanosensory 
neurons under the mec-4 promoter (Sun et al., 2014). GCaMP is a modified GFP with 
calmodulin, enabling GFP fluorescence as a function of calcium binding to calmodulin. 
In addition, this construct is then linked to an mCherry tag by an SL2 linker to enable 
ratiometric calcium imaging. This strain was crossed into ogt-1 mutants for analysis of 
calcium dynamics. 
 
For calcium imaging experiments, C. elegans were placed on 4% agarose pads with 
0.2% tetramisole, an acetylcholine receptor agonist which paralyzes the muscles to 
prevent movement (Sun et al., 2014). The femtosecond laser was calibrated to produce 
25nJ pulses and each injury consisted of three 0.5 second exposures. The ALM neuron 
was identified and an axonal cut site was determined 20 micrometers from the cell body. 
A timelapse movie consisting of 30 seconds before cutting and 5 minutes after cutting 
was recorded in both green and red channels simultaneously by taking the fluorescent 
signal, dividing it into red and green counterparts, and diverting this signal to 
independent regions of a CCD camera. Analysis was achieved by taking the ratio of 
green to red as follows: 
 






Signals were then normalized to the starting timepoint and graphs generated with Matlab 
as changes compared to starting baseline over time. 
 
2.6 Western Blotting in whole C. elegans lysates 
 
To assess protein O-GlcNAc levels, 200 young adult worms of each genotype 
were isolated by rinsing the agar plates with M9 buffer and washing and pelleting the 
animals three times by spinning down at 1,000 xg for 5 minutes. Animals were 
resuspended in 40 uL of Lysis Buffer (20 mM Tris-Cl, 137 mM NaCl, 10% glycerol, 1% 
Triton X-100 and 1X protease and phosphatase inhibitor cocktail (AbCam)) and 
sonicated using maximum power output (10 second sonication, 30 second off – repeated 
3 times). The lysate was then cleared by centrifugation at 15,000 xg for 20 minutes.  
 
Samples were mixed with 2X or 6X Laemmli Buffer and 1X DTT and heated at 
95°C for 10 minutes. Western blotting was conducted by running 16 microliters of 
sample and 5 microliters of ladder (Chameleon 800 Li-COR) on a 2-10% gel (NuPage) 
with 1X MOPS running buffer (BioRad) at 200V for 1 hour. Proteins were transferred to 
a low-fluorescence PVDF membrane using 1X Transfer buffer with Methanol at 35V for 
1 hour. The membrane was blocked in blocking buffer in TBS (Odyssey) and then 
incubated with anti-O-GlcNAc (RL2 – EMD Millipore) and anti-beta-tubulin overnight at 
4°C. A combination of anti-mouse (Green – 700nm) and anti-rabbit (Red – 800nm) 




An infrared ladder was used to assess and verify protein size (LiCOR). Densitometry was 
conducted with Licor ImageStudio Lite (Li-COR).  
 
2.7 Mechanosensory Neuron-Specific RNAi Feeding 
 
To assess the function of certain genes, an RNAi feeding protocol was developed 
based in part off of a previous protocol(Calixto et al., 2010).  Bacteria from both the 
Ahringer and Vidal libraries were used. Colonies were streaked out on bacterial agar 
plates containing carbenicillin (100µg/mL) and grown at 37°C overnight. The next day, 
colonies were selected and grown in 6 mL of LB with carbenicillin (100µg/mL) 
overnight at 37°C. From this subculture, 200µL was spread onto NGM agar plates 
containing carbenicillin (100µg/mL) and 2 mM IPTG. Plates were dried and incubated at 
room temperature for two days in the dark under aluminum foil to protect the IPTG from 
degradation.  
 
For mechanosensory neuron specific RNAi gene knockdown, TU3568 (sid-
1(pk3321) him-5(e1490) V; lin-15B(n744) X; uIs71 [(pCFJ90) pmyo-2::mCherry + pmec-
18::sid-1]) was employed (Calixto et al., 2010). This strain has RNAi sensitivity 
specifically in the mechanosensory neurons and is RNAi resistant in all other tissues. 
This is enabled by expressing the double-stranded RNA channel, sid-1, in the 
mechanosensory neurons but mutating this channel in all other tissues (Calixto et al., 
2010). We validated this approach in several ways. First, RNAi against GFP in the 




worms with RNAi against targets that are known embryonic lethal or have developmental 
defects that prevent reaching to adulthood (daf-15, hmgr-1, and itr-1 among others). In 
any case, we did not see any embryonic lethality or developmental defect (data not 
shown). TU3568 was crossed into both the ogt-1 and oga-1 mutant backgrounds. Six to 
ten gravid adults were bleached and embryos were allowed to hatch and crawl onto 
RNAi-bacteria plates. Once the F1 generation reached adulthood, 30 gravid adults were 
picked onto fresh plates and allowed to lay eggs for 3-4 hours. The day 1 adults of the F2 
generation were then analyzed in our regeneration assay as detailed above.  
 
2.8 GSK-3 Overexpression Studies 
 
GSK-3 is a known regulator of axon regeneration and is also influenced by O-
GlcNAcylation. To assess the impact of GSK-3 on axon regeneration in the ogt-1 mutant, 
KN131 (huIs24 [phsp-16.2::gsk-3; gpa-15::gfp; dpy-20(+)]; mec-7::GFP) was crossed 
into ogt-1 (ok1474) mutants. This strain has the gsk-3 gene under the control of the heat-
shock hsp-16.2 promoter (Korswagen et al., 2002). Axotomies were performed as 
detailed in the axon regeneration protocol. After axotomy, nematodes were either placed 
at 30°C for 2 hours to induce gsk-3 expression and then returned to 20°C or kept at 20°C. 
Regeneration was examined 24 hours after injury. 
 
2.9 DAF-16 Subcellular Localization 
To determine if DAF-16 subcellular localization was influenced by O-GlcNAc 




daf-16(mu86); muIs61 [(pKL78) daf-16::GFP + rol-6(su1006)] with oga-1 mutants (Lin 
et al., 2001). GFP localization was observed at the young adult stage by placing animals 
on 2% agar pads with 0.1% tetramisole for immobilization. Images were taken with a 
Nikon 20X objective. Animals were analyzed by examining the localization of the GFP 
signal in intestinal cells as either primarily nuclear or cytoplasmic. As a positive control 
to ensure DAF-16 can translocate into the nucleus, animals were heat-shocked at 37°C 
for 15 minutes to induce nuclear localization of DAF-16::GFP.  
 
2.10 Oxidative Stress Imaging 
 
Imaging of oxidative stress using the mitoROGFP sensor was performed with a 
Zeiss LSM 700 Laser Scanning Confocal Microscope (Melentijevic et al., 2017). 
mitoROGFP is a redox-sensitive GFP with cysteines placed at amino acids 147 and 204. 
These cysteines undergo reversible reduction/oxidation which in turn alters the ability of 
the molecule to be excited at either around 400nm or around 480nm. Oxidation of these 
cysteines increases excitation at 400nm, while reduction enhances 480nm excitation. A 
ratio of the emission at around 510nm between the two excitation wavelengths provides a 
relative oxidative status of the cellular environment. Uncut controls or 3 hours post cut C. 
elegans were mounted on 8% agarose pads and immobilized with a bead slurry as 
described above. Sequential line scanning was performed with 1.5% laser intensity and 
450 gain. Ratiometric imaging was performed by dividing mean emission intensity at 518 
nm resulting from 405 nm excitation to that resulting from 488 nm excitation after 




ImageJ RatioPlus plugin and assigning pixel values to a LUT chart in order to visualize 
oxidative status of the mitochondria in the cell body.  
 
2.11 Mitochondrial Tracking 
 
Imaging dynamics of mitochondria was performed by crossing NM3627 jsIs1073 
[pmec-7::TagRFP-mito::CBunc-119]; jsIs821 [pmec-7::GFP::rab-3; unc-119] with ogt-1 
and oga-1 mutants (Kumar et al., 2010). Axons were cut as above but 60 micrometers 
from the cell body. Reimaging occurred as above with a five-minute time-lapse in one Z-
plane at one frame per second. Kymographs and data analysis were conducted with 
Kymolyzer (Pekkurnaz et al., 2014). In this program, a line in the X/Y plane is chosen 
corresponding to the axon. In our studies, we chose the 60 micrometers before the axonal 
injury immediately adjacent to the neuronal cell body. This was to normalize axon length 
and width as much as possible, as regenerating processes can be thinner and exhibit 
branched complexity that make it difficult to trace a line. Once chosen, a kymograph is 
made by taking the line selected in X/Y, redrawing it to a straight line in X, and taking 
the time component and placing it in the Y direction. Thus, a straight line with constant Y 
is interpreted as no movement whereas changes in Y are interpreted as movement. Each 
particle was individually traced by hand and total length travelled, speed 





 2.12 Axon Regeneration in Mouse Cortical Neurons in vitro 
 All mouse experiments and culture preparation were conducted in the laboratory 
of Zhigang He at Harvard University. Animals were cared for according to the standards 
set by the Harvard University Institutional Animal Care and Use Committee (IACUC) 
(IACUC #18-04-3670R). Mouse cortical neurons were isolated by obtaining timed 
pregnant C57BL/6 mice from Charles River Labs. Embryonic day 18 neuronal cultures 
were isolated by euthanization of the pregnant female via CO2 and rapid cervical 
dislocation. The embryos were then removed and isolated into a dish. The head of each 
embryo was rapidly decapitated, the skull removed, and the cortex isolated. Neuronal 
cells were then isolated by both mechanical and chemical means. Neurons were plated at 
a density of 150,000 per well in 6 cm dishes on glass coverslips coated in laminin. 
Neurons were cultured with neurobasal media supplemented with B27 and glutamine, 
changed every other day, and allowed to mature at 37°C for seven days in culture. 
Cultures were transported to Boston University in temperature controlled chambers in 
under 20 minutes the day before axotomy experiments.  
 
 Following maturation, neuronal cultures were treated with either DMSO or 2 µM 
of ST045849 (OGT inhibitor) for 12 hours. Neuronal medium was then changed to 
Hibernate Low Fluorescence Media supplemented with B27, glutamine, and the 
corresponding drug. Neurons were placed in a temperature-controlled chamber on a 
Nikon Ti-2000 inverted fluorescent microscope and imaged using a Nikon 60X objective. 




of 1Mhz. Axons were cut 60um away from the cell soma and followed for 6 hours post-
injury. The percent of neurons displaying a growth cone by 6 hours were measured, as 
well as axonal outgrowth.  
 
2.13 Optic Nerve Crush and Axon Regeneration in Mice in vivo 
 All procedures and anesthetics were approved by Harvard University Institutional 
Animal Care and Use Committee (IACUC) (IACUC #18-04-3670R). One month old 
male 10X backcrossed OGT floxed mice, B6.129-Ogt tm1Gwh/J, were used for the optic 
nerve injury and regeneration analysis. Optic nerves were injected with either Cre 
recombinase (n=6) or vehicle control (n=6). Expression was induced for 2 weeks. Optic 
nerves were crushed with forceps. After 2 weeks, the axonal tracer CTB-555 was injected 
and 2 days later retinas and optic nerves were dissected and isolated. Whole mount 
staining of the retina and optic nerve was performed for analysis of the axonal 




 CHAPTER THREE 
Results 
 3.1 The Influence of O-GlcNAc on Axon Regeneration in 
Caenorhabditis elegans 
 
To assess the role of O-GlcNAc on axon regeneration in C. elegans, we 
utilized mutants with large deletions in the coding regions of the O-GlcNAc 
Transferase (OGT) and O-GlcNAcase (OGA) genes. As with other organisms, C. 
elegans only encodes one gene for each enzyme. These mutants were obtained by 
large-scale mutagenesis during the C. elegans Gene Knockout Project. The ogt-1 
(ok1474) mutant has a 1300bp deletion and is a functional null mutant. The oga-1 
(ok1207) mutant is a 1700bp deletion resulting in a removal of exons 3-7, deleting 
the entire catalytic domain and resulting in a functional null mutant. We 
confirmed these mutants functionally by western blotting against O-GlcNAc. 
Accordingly, ogt-1 mutants display no detectable O-GlcNAcylation whereas oga-
1 mutants display hyper-O-GlcNAcylation (Figure 3.1).  
 
The mechanosensory neurons of C. elegans are a classic model of 
regeneration due to their simple morphology and proximity to the surface, which 
greatly facilitates laser axotomy. To visualize these neurons, we crossed the ogt-1 
and oga-1 mutants into the zdis5 background, which encodes a GFP under the 




examined their regenerative growth 24 hours after injury of the Anterior Lateral 




Figure 3.1 Protein O-GlcNAc Levels are Altered in O-GlcNAc 
Mutants 
Representative western blot of O-GlcNAc levels in wildtype and O-
GlcNAc mutant whole worm lysates. Anti-RL2 ant antibody primarily 
detects two O-GlcNAcylated nucleoporins. Tubulin was used as a 




and oga-1 mutants displayed enhanced regeneration with ~70% and ~40% 
regrowth above wildtypes, respectively (Figure 3.2). In addition, we examined a 
different neuron to confirm our findings. Examining the Posterior Lateral 
Microtubule (PLM) neuron also revealed that both ogt-1 and oga-1 mutants can 
enhance regeneration, although in this case the oga-1 mutant had greater 
regenerative potential than the ogt-1 mutant (Figure 3.2). 
3.1.2. O-GlcNAc Acts Cell Intrinsically to Enhance Axon Regeneration 
 
To assess whether the effect of O-GlcNAc on axon regeneration is cell-
intrinsic or extrinsic, we utilized a mechanosensory neuron-specific RNAi strain 
(TU3568) which has the sid-1 dsRNA channel knocked out in all cells and then 
reintroduced specifically in the mechanosensory neurons under the mec-18 
promoter. This allows for neuron-specific knockdown of target genes without 
influencing other tissues. We cultured C. elegans on ogt-1 or oga-1 RNAi 
producing bacteria for two generations and then examined 24-hour regenerative 
growth. Knockdown of both ogt-1 and oga-1 specifically in the mechanosensory 
neurons significantly enhanced axon regeneration in the ALM (Figure 3.3). This 








Figure 3.2 O-GlcNAc Mutants Have Enhanced Axon Regeneration 
A - Representative images of axon regeneration in the ALM neuron 24 hours 
after laser axotomy in wildtype and O-GlcNAc mutants. Scale bar: 20 
micrometers. 
 
B - Average regenerative outgrowth of ALM neuron 24 hours after injury for 
wildtype and O-GlcNAc mutants with and without treatment of a glucose 
transport inhibitor (phloretin), D-glucose, or D-mannitol.  
 
C -  Average regenerative outgrowth of PLM neuron 24 hours after injury for 
wildtype and O-GlcNAc mutants. 
 
Shown is mean ± s.e.m. One-way ANOVA ***p<0.001, **p<0.01, *p<0.05. 










Figure 3.3 O-GlcNAc acts Cell Intrinsically to Enhance Regeneration 
Average regenerative outgrowth 24 hours after injury with RNAi knockdown 
of ogt-1 and oga-1 in the mechanosensory neurons. Shown is mean ± s.e.m. 




3.1.3. O-GlcNAc Modifying Small Molecule Inhibitors Can Enhance Axon 
Regeneration 
 
We then determined whether pharmacological intervention targeting the 
O-GlcNAc enzymes could also enhance axon regeneration. To inhibit the OGT, 
we treated C. elegans with 50µM ST045849. This inhibitor was discovered 
through high-throughput chemical screening and is proposed to inhibit the OGT 
by binding to the active site. Treatment of C. elegans with 50µM ST045849 for 
24 hours produced a significant decrease in O-GlcNAc levels, as detected by 
western blotting (Figure 3.4, western not shown). Treating C. elegans with 
ST045849 for 24 hours before injury and 24 hours after injury resulted in 
enhanced regeneration compared to DMSO treated controls (Figure 3.4). To 
inhibit the OGA, we utilized Thiamet G, a highly characterized inhibitor which 
resembles a glucosamine moiety to inhibit the active site of the OGA. Treatment 
of C. elegans for 24 hours with 2µM Thiamet G resulted in enhanced O-GlcNAc 
levels (Figure 3.4). In addition, treating C. elegans for 24 hours before and after 
injury resulted in significantly enhanced regeneration compared to EtOH treated 
controls (Figure 3.4). The results above suggest that modulation of O-GlcNAc 
levels toward one extreme or the other can significantly enhance axon 











Figure 3.4 O-GlcNAc Small-Molecule Inhibitors Enhance Regeneration 
(Left) Average regenerative outgrowth 24 hours after injury of wildtype or 
ogt-1 mutants with and without the OGT inhibitor (ST045849).  
 
(Right) Average regenerative outgrowth 24 hours after injury of wildtype or 






3.2 O-GlcNAc Acts at a Late Stage of Axon Regeneration 
 
 Axon regeneration involves the resealing of the membrane, initiation of a 
growth cone, and axon extension. These events occur at distinct times in C. 
elegans with resealing and component degradation occurring within the first few 
hours, a growth cone forms between 3-5 hours, and axon extension occurs 
between 6-24 hours. We conducted time-lapse analysis of growth in ogt-1 and 
oga-1 mutants and examined regrowth at 1, 3, 5, 12, and 24 hours.  Interestingly, 
axon regrowth in both mutants was indistinguishable from wildtypes from 0 to 12 
hours post injury. However, between 12 and 24 hours post injury, regeneration of 
both ogt-1 and oga-1 was enhanced above wildtypes suggesting that both mutants 
act at a later stage of axon regeneration (Figure 3.5). 
 
We also examined filopodial dynamics, which are actin-based early 
extensions. Previous work has identified these transient structures extending from 
both the site of damage and the cell body preceding axonal extension (Sun et al., 
2014). We found that neither the ogt-1 or oga-1 mutants displayed differences 
compared to wildtype in the time to first filopodial extension when examining 1 
and 3 hour timepoints. By 1 hour post injury, roughly 40% of neurons display 
filopodia. The remaining 60% display filopodia by 3 hours post injury. We then 
examined the dynamics of filopodia by measuring the number of them in the same 




As we have seen previously, filopodial number increases with time in wildtypes. 
We see that ogt-1 and oga-1 mutants follow a similar trend with the exception that 
oga-1 mutants display significantly fewer filopodia at the 5-hour time point 
(Figure 3.5).  
 
 To confirm that O-GlcNAc mutants act at a late-stage of regeneration, we 
examined the relationship between DLK-1, an early effector of regeneration, and 
the O-GlcNAc mutants. DLK-1 is a Dual Leucine Zipper Kinase which acts in the 
conserved p38 MAPK pathway to enable regeneration through a multitude of 
mechanisms.  As DLK-1 is a known early modulator of axon regeneration (Nix et 
al., 2014), we hypothesized that mutations in dlk-1 should knockdown both ogt-1 
and oga-1 regeneration. Mutations in dlk-1 modestly reduce wildtype axon 
regeneration 24 hours after injury in accordance with what our lab and others 
have observed (Chung et al., 2016). Further, mutations in dlk-1 significantly 
suppressed both ogt-1 and oga-1 mutant regeneration in accordance with dlk-1 







Figure 3.5 Dynamics of Axonal Outgrowth in O-GlcNAc mutants  
A. Time-lapse of axon regeneration 1hr, 3hr, 5hr, 12hr, and 24hr after 
injury. 
 
B. Percent of neurons displaying filopodia at 1 hr and 3 hr post-injury. 
 
C. Number of filopodia over time between wildtype, ogt-1, and oga-1 
mutants.  
 
Shown is mean ± s.e.m. One-way ANOVA ***p<0.001, **p<0.01, *p<0.05. 









Figure 3.6 DLK-1 Loss-of-Function Inhibits O-GlcNAc Mutant 
Regeneration  
Genetic epistasis analysis of 24 hour regeneration between dlk-1 mutants and O-
GlcNAc mutants. Shown is mean ± s.e.m. One-way ANOVA ***p<0.001, 
**p<0.01, *p<0.05. Stars compare groups to wildtype control except for brackets 






3.3 O-GlcNAc is a Nutrient Responsive Post-Translational 
Modification during Axon Regeneration 
 
The O-GlcNAc modification responds dynamically to changes in glucose 
as O-GlcNAc synthesis is dependent on glucose metabolism through the 
hexosamine biosynthetic pathway. We examined whether altering glucose levels 
in our regeneration assays could influence regeneration. Western blots revealed 
that 100mM D-glucose supplementation elevated O-GlcNAc levels to an extent 
similar to what we observed in oga-1 mutants (Figure 3.7). Treating wildtype 
animals with 100mM glucose for 24 hours before and after axon injury resulted in 
a significant increase in axon regeneration (Figure 3.2). Glucose treatment did not 
further enhance regeneration seen in ogt-1 and oga-1 mutants. In addition, 
treatment of C. elegans with 100mM D-mannitol as an osmolarity control had no 
effect on wildtype regeneration (Figure 3.2). We then inhibited glucose uptake 
with 1mM phloretin, a dose previously established in C. elegans. Treatment with 
phloretin did not affect wildtype but significantly suppressed both ogt-1 and oga-
1 mutant regeneration (Figure 3.2). From these results, we conclude that O-
GlcNAc is responsive to changes in glucose and that both ogt-1 and oga-1 
regeneration are dependent on glucose. Mutants lacking O-GlcNAc post 
translational modifications could be enhancing glucose utilization in 
compensation for a perceived metabolic deficit and thus require glucose transport 













Figure 3.7 O-GlcNAc is a Glucose-Responsive Modification 
O-GlcNAc levels as measured by western blotting as in Figure 3.1. O-GlcNAc 
(RL2 signal) levels normalized to tubulin. 100mM glucose treatment enhances 





3.4 O-GlcNAc does not act through calcium-dependent mechanisms 
  
Several lines of evidence from mouse studies in vitro and in vivo have 
suggested that O-GlcNAc can modify and affect the function of proteins 
important in calcium signaling (Rengifo et al., 2007). During axon regeneration, 
calcium signaling is important in nearly all aspects, from membrane resealing to 
axonal extension (He and Jin, 2016).  Proteomics have revealed that the inositol 
triphosphate receptor (IP3R), which governs the mobilization of calcium stores 
from the endoplasmic reticulum, and the calcium/calmodulin-dependent kinase 
(CAMK), an important effector kinase, are O-GlcNAcylated (Erickson et al., 
2013; Rengifo et al., 2007). Both of these proteins play an essential role in axon 
regeneration. Endoplasmic reticulum release of calcium through both the IP3R 
and the ryanodine receptor, is the primary factors responsible for the enhanced 
calcium release upon axonal injury and this response is important for regeneration 
in C. elegans (Sun et al., 2014). O-GlcNAcylation of the IP3R in cultured mouse 
neurons inhibits the channel, whereas lack of O-GlcNAcylation promotes the 
open state (Rengifo et al., 2007). The sites of the IP3R that are O-GlcNAcylated 
are conserved in the C. elegans gene, itr-1. We hypothesized that lack of O-
GlcNAcylation, via the ogt-1 mutant, may enhance regeneration by increasing 
IP3R activity and calcium release. We generated double mutants between the O-




knockout is not viable. Loss of itr-1 function did not alter ogt-1 mutant 








Figure 3.8 Calcium Dynamics are not Responsible for OGT Mutant 
Regeneration 
 
A. GCaMP calcium signal before and after axonal injury in the axon tip 
(Left) and the cell body (Right). Red trace is wildtype and Yellow 
trace is ogt-1 mutant. Time is 5 minutes. 
 
B. Effect of itr-1 loss-of-function mutant on 24-hr. regeneration of ogt-1 
mutant. 




We then examined calcium dynamics during regeneration in the ogt-1 
mutant. Our previous work has revealed that calcium release from the ER makes 
up a large portion of the calcium signal upon axonal injury (Sun et al., 2014). This 
elevation in calcium can continue up to five hours post-injury and is important for 
the regenerative response, as mutants in the ryanodine receptor do not have these 
calcium dynamics and fail to regenerate to the extent of wildtypes. We utilized 
GCaMP3.0 to examine these calcium dynamics. Analysis of five minute videos 
after injury revealed no significant difference in the calcium dynamics between 
wildtype and ogt-1 mutants (Figure 3.8). Examining levels up to five hours post-
injury also revealed no significant difference (Figure 3.8). This data further 
suggested a lack of involvement of the ITR-1 and the ER calcium response.  
 
Finally, we inhibited global calcium levels by applying the calcium 
chelator EGTA to our culture conditions. We found that altering calcium levels 
during experiments, with calcium in our buffers and NGM plates gave us wide 
variability. To eliminate this, we treated plates with 7.5mM EGTA for 24 hours 
before placing C. elegans on them. In addition, we used a calcium-free S-buffer to 
transfer worms during our cutting protocol and supplemented EGTA in the pads 
used to hold the worms on the microscope. Using this approach, we found that 
EGTA addition did not affect regenerative outgrowth in ogt-1 or oga-1 mutants 
(Figure 3.8). We concluded from this series of data that O-GlcNAc likely does not 




3.5 O-GlcNAc does not act through cyclic AMP-dependent mechanisms 
 
 O-GlcNAc has previously been shown to modulate axon growth in 
cultured neurons and memory formation in mice through directly modifying the 
cAMP Responsive Element Binding (CREB) protein (Rexach et al., 2012). CREB 
is a transcription factor within the cAMP signaling pathway, which is also 
important for a pro-regenerative response. Elevations in cAMP leads to the 
activation of Protein Kinase A (kin-2) and the activation of the CREB (crh-1) 
transcription factor and other bZip (cebp-1 and ets-4) transcription factors to 
elevate the transcription of genes which enhance regeneration (Li et al., 2015). To 
examine whether the cAMP signaling pathway is important for the enhanced 
regeneration of the O-GlcNAc mutants, we generated double mutants between the 
O-GlcNAc mutants and the CREB transcription factor, crh-1. Loss of crh-1 
function did not affect either ogt-1 or oga-1 mutant regeneration (Figure 3.9). 
Likewise, using a phosphodiesterase (pde-4) mutant, which has been previously 
shown to enhance regeneration by decreasing cAMP degradation, did not have 
any effect on the regeneration of ogt-1 or oga-1 mutants (Figure 3.9). However, 
pde-4 single mutants display enhanced regeneration akin to the ogt-1/oga-1 
alleles. This suggests two different scenarios. First, the two signaling pathways 
act independent from one another, as loss of crh-1 function had no effect and 
enhancing the cAMP pathway was not additive, suggesting we have hit a ceiling 




cAMP pathways are redundant at some unknown level.  Given the lack of 
involvement of the major downstream transcription factor crh-1/CREB and 
calcium dependent pathways which are important for cAMP mediated 
regeneration, we favor a model in which O-GlcNAc and cAMP signaling have 








Figure 3.9 Cyclic AMP Pathway is not Essential for O-GlcNAc Mutant 
Regeneration 
 
Loss of pde-4 function (enhancing cAMP levels) enhances regeneration but 
has no effect on ogt-1 or oga-1 mutant regeneration. Loss of the downstream 
transcription factor controlled by cAMP, crh-1/CREB, has no impact on O-
GlcNAc mutant regeneration. Shown is mean ± s.e.m. One-way ANOVA ns 




3.6 O-GlcNAc Acts through a Toggle Switch-like Mechanism in the 
Insulin-Signaling Pathway 
 
Advances in mass spectrometry technology revealed that components of 
the insulin-signaling pathway in mammals are highly modified by O-GlcNAc 
(Whelan et al., 2010). Modifications occur at multiple strata of the pathway 
enabling rapid temporal response to changing intracellular nutrient status. For 
example, the insulin-receptor substrate (an adapter which interacts with the 
insulin receptor), the AKT kinase, and the FOXO transcription factor have all 
been identified as targets of O-GlcNAc (Whelan et al., 2010). In general, addition 
of O-GlcNAc results in the inhibition of insulin-signaling. Genetic epistasis 
analysis has also found that components of the insulin-signaling pathway interact 
with O-GlcNAc to govern lifespan, metabolism, and the stress response in C. 
elegans (Love et al., 2010; Rahman et al., 2010). We performed a large genetic 
epistasis screen by generating double mutants between components of the insulin-
signaling pathway and O-GlcNAc enzymes. We examined the insulin receptor 
(daf-2 e1370), the phosphotide inositide kinase (age-1), the AGC kinases (akt-1 
ok525, akt-2 ok393, and sgk-1), the FOXO transcription factor (daf-16 mu86). 
The results revealed the possibility of a toggle-like switch mechanism that 






3.7 Lack of O-GlcNAc Enhances Axon Regeneration through AKT-1 
 
 Examining the insulin-signaling pathway revealed that the enhanced 
regeneration of ogt-1 mutants displayed a complex interaction (Figure 3.10). 
Loss-of-function of ogt-1;daf-2 resulted in regeneration comparable to either 
single mutant, suggesting they act within a similar pathway. Likewise double 
mutants between ogt-1;age-1 also had regeneration similar to either ogt-1 or age-
1 single mutants. Interestingly, loss of akt-1 function specifically inhibited ogt-1 
regeneration to an extent comparable to wildtype. Mutations in akt-2 had no effect 
on ogt-1 regeneration. This suggests that ogt-1 mutants act specifically through 
akt-1 activation to enhance axon regeneration. In accordance with this, loss of 
daf-16 function had no effect on ogt-1 mutant regeneration (Figure 3.10).  
 
3.8 ARK-1 is Genetically Upstream of AKT-1 during Regeneration of 
OGT mutants 
 
  Canonically, the PI3K (age-1) is an upstream activator of AKT-1 in the 
insulin-signaling pathway. However, we clearly see that ogt-1 mutant 
regeneration is dependent on AKT-1 but independent of AGE-1 suggesting there 
is a different upstream activator (Figure 3.10). A known alternative upstream 






Figure 3.10 Insulin-Signaling Pathway Epistasis Analysis with ogt-1 Mutants. 
 
Loss-of-function mutants in daf-2, age-1, akt-1, akt-2, and daf-16 in combination with 
the ogt-1 mutant allele. (-) indicates loss-of-function allele and (++) indicates gain-of-
function (gof) allele. Only loss-of-function in akt-1 suppressed ogt-1 mutant 
regeneration. Shown is mean ± s.e.m. One-way ANOVA ***p<0.001, **p<0.01, 






Homology searches in C. elegans revealed that the ACK ortholog is ark-1 
with ~88% similarity. The mechanism of activation in mammalian systems occurs 
when ACK is activated through growth factor receptors or stress-induced signals 
and leads to the phosphorylation of tyrosine 186 of AKT. This then allows AKT 
to be recruited to the membrane for further activation. To examine if ACK/ARK-
1 is involved in ogt-1 mediated regeneration, we generated double mutants 
between ogt-1;ark-1. Interestingly, ogt-1;ark-1 double mutants had significantly 
reduced outgrowth compared to ogt-1 mutants alone (Figure 3.11).  
 To determine whether ARK-1 lies upstream or downstream of AKT-1, we 
utilized an AKT-1 gain-of-function allele and restored AKT-1 activity in ogt-
1;ark-1 double mutants. The restoration of AKT-1 activity rescued the 
regeneration defect observed in ogt-1;ark-1 mutants suggesting that AKT-1 is 
either downstream or acts in parallel to ARK-1 (Figure 3.11). To confirm that 
AKT-1 is downstream, we generated ogt-1;ark-1;akt-1 loss-of-function mutants. 
Loss of both ARK-1 and AKT-1 did not further reduce the regeneration of ogt-
1;ark-1 mutants suggesting that ARK-1 and AKT-1 act within the same pathway 
and that ARK-1 is genetically upstream of AKT-1 (Figure 3.11).  
 
3.9 Identification of Factors Downstream of AKT-1 that Mediate the 





 Several signaling pathways have been identified that are downstream of 
AKT and act on axonal growth or regeneration. A prominent example is the 







Figure 3.11 ARK-1 is Genetically Upstream of AKT-1 in ogt-1 Mutant 
Regeneration  
 
Genetic epistasis analysis between ark-1, akt-1 and ogt-1 mutants. (-) indicates 
loss-of-function allele and (++) indicates gain-of-function allele. Loss-of-function 
in ark-1 suppressed ogt-1 mutant regeneration. Gain-of-function in akt-1 restored 
ogt-1;akt-1 mutant regeneration. Shown is mean ± s.e.m. One-way ANOVA 
***p<0.001, **p<0.01, *p<0.05. Stars compare groups to wildtype control except 




pathway, in which AKT can mediate mTOR activation resulting in enhanced 
regeneration through local protein translation and potentially metabolic means. To 
examine whether mTOR is important for ogt-1 mutant regeneration, we treated 
animals with the mTOR inhibitor rapamycin. Treatment of wildtype animals with 
rapamycin had no effect on wildtype axon regeneration. As a positive control, 
treatment of PTEN/daf-18 mutant animals, which display mTOR-dependent 
enhanced regeneration, was effectively eliminated with rapamycin treatment. 
However, we did not observe any decrease in ogt-1 mutant regeneration upon 
rapamycin treatment (Figure 3.12). We further tested this by knocking down the 
regulatory associated protein of mTOR (RAPTOR/daf-15). Neuron-specific RNAi 
against daf-15 had no effect on ogt-1 mutant axon regeneration (data not shown). 
From this, we concluded that the enhanced regeneration of ogt-1 mutants is 
independent of mTOR activity.  
AKT is known to negatively regulate the glycogen synthase kinase 3 beta 
(GSK-3b) and many studies have linked GSK-3b to axonal growth and 
regeneration, although a consensus on whether it provides a positive or negative 
role remains controversial and may depend on neuronal type (Leibinger et al., 
2017). Given that AKT is a negative downstream regulator of GSK-3b, we 
hypothesized that over-expression of GSK-3b may inhibit regeneration of ogt-1 
mutants. To test this, we utilized a heat-shock inducible gsk-3 transgenic animal. 
Heat-shocking for two hours at 30°C after axonal injury was sufficient to 




experiment in the ogt-1 mutant background resulted in a slight but significant 








Figure 3.12 mTOR or GSK-3b Signaling is not Responsible for ogt-1 
Mutant Regeneration 
 
A. mTOR inhibitor rapamycin is unable to suppress ogt-1 mutant 
regeneration but able to suppress PTEN/daf-18 regeneration.  
 
B. (Left) Heat-shock inducible gsk-3 expression mildly suppresses both 
wildtype and ogt-1 mutant regeneration. The ratio of enhanced 
regeneration between wildtype and ogt-1 remains conserved.  
 
(Right) Heat-shocking has no effect on axon regeneration in wildtype 
controls without the heat-shock inducible gsk-3 allele.  
 
Shown is mean ± s.e.m. One-way ANOVA ***p<0.001, **p<0.01, 
*p<0.05. Stars compare groups to wildtype control except for 




3.12). However, the regeneration observed in ogt-1 mutants with gsk-3 
activation was still much higher than those of wildtypes. From this data, we 
concluded that while gsk-3 has an effect on axon regeneration, it is independent 
from that of ogt-1.  
 
Lastly, we examined the hypothesis that AKT may be regulating 
glycolysis. Notably, AKT has many roles in glucose homeostasis, including 
modulating cellular glucose uptake by acting on the GLUT4 transporter and 
affecting glycolysis. We examined both of these mechanisms. First, we knocked 
down every potential glucose transporter with neuron-specific RNAi to determine 
whether AKT was acting in a similar fashion to that in mammals. Knockdown of 
aat-9, glt-1, fgt-1, swt-7, mct-2, mct-4, mct-5, mct-6, and ZK829.9 individually 
failed to inhibit axon regeneration in the ogt-1 background (Figure 3.13). 
However, inhibition of all glucose transport pharmacologically with phorletin 
repressed regeneration suggesting multiple transporters may be acting in parallel.  
 
To test whether glycolysis is involved, we again performed neuronal-
specific RNAi against an enzyme important in glycolysis. C. elegans encodes 
multiple redundant genes for most of the glycolytic enzymes, preventing their 
analysis by RNAi. However, the phosphoglycerate kinase (pgk-1) is only encoded 
for by one gene and, therefore, we conducted a knockdown of pgk-1 in ogt-1 




regeneration (Figure 3.13). To confirm this, we used a loss-of-function mutant in 
the phosphofructokinase-1.1 (pfk-1.1) shown to be important in neuronal 
glycolysis in C. elegans. While pfk-1.1 mutants failed to affect axon regeneration 
in a wildtype background, pfk-1.1 loss-of-function significantly inhibited ogt-1 
enhanced regeneration (Figure 3.13). Taken together, these data strongly suggest 
that ogt-1 mutants enhance regeneration through glycolysis. To further confirm 
this, we used a competitive inhibitor of glycolysis, 2-deoxy-D-glucose (DOG). 
Treatment of wildtype worms with either 5mM or 10mM DOG resulted in no 
effect on wildtype regeneration. However, treatment of ogt-1 mutants resulted in a 
dose-dependent decrease in axon regeneration with 10mM being highly effective 










Figure 3.13 Glycolysis is Essential for ogt-1 Mutant Regeneration 
 
A. RNAi against GFP is able to inhibit GFP expression specifically in 
mechanosensory neurons. 
B. Knockdown of glucose transporters did not affect ogt-1 mutant 
regeneration.  
C. Mechanosensory neuron-specific RNAi against the glycolytic enzyme 
phosphoglycerate kinase 1 (pgk-1) in the ogt-1 background.  
D. Mutation of phosphofructokinase-1.1 (pfk-1.1) in wildtype and ogt-1 
backgrounds.  
E. Treatment of wildtype and ogt-1 mutants with the non-hydrolyzable glucose 
analog 2-deoxy-D-glucose.  
F. Mechanosensory neuron-specific RNAi against the NADH dehydrogenase 
iron-sulfur protein 2 (nduf-2.2) in the ogt-1 background. 





To establish whether glycolysis is coupled to or independent of 
mitochondrial oxidative phosphorylation, we then knocked down an essential 
NADH dehydrogenase iron-sulfur protein 2 (nduf-2.2), a component of the 
electron-transport chain important for regeneration. Knocking down nduf-2.2 had 
no effect on ogt-1 mutant regeneration suggesting that the enhanced glycolysis is 
responsible for the regeneration independently of mitochondrial oxidative 
phosphorylation (Figure 3.13).  
 
3.10 Abundance of O-GlcNAc Acts through the FOXO/DAF-16 
transcription factor to enhance regeneration 
 
 As the ogt-1 mutant regeneration was dependent on the insulin-signaling 
pathway, we wondered if the oga-1 enhanced regeneration also relied on this 
pathway. We conducted a genetic epistasis analysis using loss-of-function 
mutants in the insulin-signaling pathway, as explained above. Unexpectedly, oga-
1;daf-2 mutants reduced daf-2 regeneration to the extent of oga-1 mutants (Figure 
3.14). Examining the intermediate kinases AGE-1 and AKT-1 revealed no 
significant differences between double mutants and oga-1 mutants. However, 
loss-of-function of the FOXO/DAF-16 transcription factor significantly reduced 
oga-1-dependent regeneration. This data suggested that oga-1 acts downstream of 
daf-2 but upstream of daf-16 to enhance regeneration. We therefore examined 




SGK-1 function significantly inhibited oga-1 regeneration to wildtype levels. This 
suggests that oga-1 acts at the level of SGK-1 to influence DAF-16 activity 
(Figure 3.14).  
 
DAF-16 can be shuttled in and out of the nucleus upon deactivation or 
activation of insulin signaling, respectively. We examined whether O-GlcNAc 
status affected DAF-16 nuclear localization by examining a DAF-16::GFP-tagged 
strain in the O-GlcNAc mutant backgrounds. As a positive control, heat-shocking 
animals at 37°C resulted in the rapid nuclear localization of DAF-16. However, 
none of the O-GlcNAc mutants produced any difference in nuclear localization of 
DAF-16 (Figure 3.15). This suggests that oga-1 mutants do not act on DAF-16 by 







Figure 3.14 Insulin-Signaling Pathway Epistasis Analysis with oga-1 Mutants. 
 
(Left) Loss-of-function mutants in daf-2, age-1, akt-1, and daf-16 in combination with 
the oga-1 mutant allele. (-) indicates loss-of-function allele and (++) indicates gain-of-
function allele. oga-1 mutant allele was able to suppress daf-2 regeneration whereas 
oga-1 regeneration was dependent on daf-16. 
  
(Right) Loss of sgk-1 function suppresses oga-1 mutant regeneration.  
Shown is mean ± s.e.m. One-way ANOVA ***p<0.001, **p<0.01, *p<0.05. Stars 









Figure 3.15 oga-1 Mutants do not have Altered DAF-16 Localization 
 
DAF-16::GFP is mostly cytosolic in oga-1 mutants suggesting it does 
not act by altering DAF-16 localization. Heat shocking induces nuclear 




3.11 OGA-1 Mutants Have a Complex Mitochondrial Phenotype 
 
 Both O-GlcNAc and DAF-16 have been strongly linked to altering 
mitochondrial dynamics by invoking mitochondrial oxidative stress pathways and 
influencing mitochondrial transport. We examined whether oga-1 mutants had 
enhanced mitochondrial oxidative stress resistance by using the mitoROGFP 
oxidative stress sensor. This sensor is a permutated GFP localized to the 
mitochondrial matrix that produces different ratios of emission depending on 
oxidative stress status. Before injury, oxidative environments were similar 
between wildtype and oga-1 mutants. However, after injury, oga-1 mutants were 
able to maintain a reduced environment compared to wildtypes 3 hours post 
axotomy (Figure 3.16).  
 
 Further, we examined mitochondrial locomotion dynamics by tagging 
mitochondria with RFP and generating five minute kymographs of their 
movements 24 hours after injury. O-GlcNAc addition has been previously shown 
to reduce mitochondrial motility by acting on the Milton protein complex. In 
accordance with this, we also observed that oga-1 mutants exhibit significantly 
reduced motility, defined as the percentage of time in motion over a five-minute 
period (Figure 3.17). Differences in mitochondrial speed and total distance 




Examining the ogt-1 mutant revealed no differences between wildtype 







Figure 3.16 oga-1 Mutants have Reduced Oxidative Stress upon Injury 
 
(Left) mitoROGFP emission ratio changes in oxidative environments. Before injury, 
oxidative stress remains the same. After injury, oga-1 mutants maintain a reduced 
environment.  
 
(Right) Pseudocolored representative images of wildtypes and oga-1 mutants post 
injury. Cell body is highlighted with a white arrow, axon cut site with a blue arrow.  
 
Shown is mean ± s.e.m. One-way ANOVA *p<0.05. Stars compare groups to 







Figure 3.17 oga-1 Mutants have Altered Mitochondrial Dynamics and Rely on 
Oxidative Phosphorylation for ATP Synthesis 
 
A. Representative kymographs of mitochondrial movement in wildtype, ogt-1, and 
oga-1 mutants 24 hours after injury. 
B. Quantitative analysis of mitochondrial dynamics. Shown are the percent time in 
motion, the mean speed, and the total length traveled.  
C. Mechanosensory neuron-specific RNAi against the NADH dehydrogenase iron-





 Finally, we examined whether mitochondrial ATP synthesis was important 
in oga-1 mutants. Interestingly, producing double mutants between oga-1 and 
mutations of genes in the electron transport chain, such as nuo-6 and isp-1, was 
not viable. To get around this, we knocked down with RNAi an essential NADH 
dehydrogenase iron-sulfur protein 2 (nduf-2.2), a component of the electron-
transport chain important for regeneration. Knocking down nduf-2.2 significantly 
reduced oga-1 mutant regeneration suggesting that oga-1 mutants rely on ATP 
generation from mitochondrial to fuel axon regeneration (Figure 3.17).  
 
3.11 Canonical DAF-16 target genes are not responsible for oga-1 
mutant regeneration 
 
 A number of genes that are transcriptionally controlled by DAF-16 have 
been identified to play a role in the mitochondrial stress response and metabolism 
(Kaletsky et al., 2016). We conducted a targeted RNAi screen against these 
components using a list of recently identified mechanosensory neuron-specific 
DAF-16 target genes. We examined oxidative stress/stress response genes (mtl-1, 
sip-1, sta-1), fatty acid metabolism (fat-3, T13C2.6), mitochondrial genes (nnt-1, 
hmgr-1). However, knockdown of these genes produced no effect on oga-1 
mutant regeneration with the exception of hmgr-1 (Figure 3.18). The hmgr-1 gene 
is the homolog of the HMG CoA-reductase, the key rate-limiting enzyme of the 




prenylation, Coenzyme Q, and dolichols. In contrast to mammals, C. elegans does 
not synthesize cholesterol via the mevalonate pathway and instead relies on 
dietary cholesterol for membranes. To confirm this hit, we knocked down 
enzymes downstream of the hmgr-1 in the mevalonate pathway. However, 
knocking down the farnesyl diphosphate synthase (R06C1.2) produced no 
reduction in oga-1 mutant regenerative outgrowth. Furthermore, inhibiting all 
downstream pathways including coenzyme Q synthesis (coq-1), protein 
prenylation (R02D3.5, F23B12.6, M57.2, and Y48E1B.3), or isopentyl tRNA 
synthesis (gro-1) also resulted in no effect in regenerative outgrowth (Figure 
3.18). Taken together, we conclude that either hmgr-1 could be a false positive in 
our screen or, excitingly, that a completely new branch of the mevalonate 








Figure 3.18 DAF-16 Target Gene Knockdown in the oga-1 Mutant Background 
RNAi knockdown of DAF-16 target genes involved in mitochondrial metabolism, 
the mitochondrial stress response, and the mevalonate pathway. One-way ANOVA. 




3.12 The effect of an OGT inhibitor on axon regeneration in mouse 
cortical neurons in vitro 
 
 We wondered whether acute inhibition of OGT could enhance axon 
regeneration in cultured mouse cortical neurons. We isolated day 18 embryonic 
cortical neurons and allowed them to grow for seven days in culture. We then 
treated the cultures with either 2 micromolar of ST045849, an OGT inhibitor, for 
12 hours before inducing axonal injury with our laser ablation system. We 
confirmed that this dose of inhibitor successfully knocked down O-GlcNAc levels 
by Western blots (data not shown). We cut an axon approximately 60 
micrometers from the cell body and observed its regenerative growth over six 
hours. Treatment with the OGT inhibitor ST045849 significantly increased the 
percentage of neurons displaying growth cones and trended toward an 
enhancement of axon regeneration, but did not reach significance, compared to 
vehicle treated controls (Figure 3.19). Further optimization of dose and treatment 







Figure 3.19 Inhibition of OGT in Regenerating Mouse Cortical Neurons 
 
(Top) Timelapse analysis of axonal injury and regeneration over 6 hours. Red arrow 
shows injury site. Yellow arrow shows the growth cone. 
 
(Bottom) Quantification of the percent of neurons displaying growth cones after 




3.12 The effect of OGT inhibition on axon regeneration in a mouse 
optic nerve crush injury model  
	
	 We then assessed whether our findings in C. elegans and in cultured 
neurons could translate to an in vivo mouse model of axon regeneration. We 
utilized a mouse line with a floxed OGT allele, which upon Cre recombinase 
injection, would produce a functional null protein. This approach was essential 
due to the embryonic lethal nature of the constitutive OGT knockout. Therefore, 
we injected an adenoviral vector encoding Cre into the retina two weeks before 
optic nerve crush. We then crushed the optic nerve, waited two weeks, and then 
injected an axonal tracer, CTB-550, to assess the extent of regeneration of the 
retinal ganglion cells (RGCs). We also examined retinal ganglion cell death. 
 In stark contrast to our C. elegans model, inhibiting OGT produced no 
beneficial regenerative effect. The amount of regeneration was comparable to 
wildtype with potentially a slight increase at the first 200 micrometer point 
(Figure 3.20 A and B). We then examined cell death and cell morphology by 
staining whole-mount retinas for the RNA-binding protein with multiple splicing 
(RBPMS), a marker of all retinal ganglion cells, and osteopontin, a marker for the 
alpha-subtype retinal ganglion cells. Interestingly, we observe that total RGC 
number is significantly decreased in OGT knockouts and that the alpha-RGCs in 
particular are affected (Figure 3.20 C,D,E, and F). This suggests that any 












Figure 3.20 OGT Inhibition has no Effect on Regeneration but Induces Cell 
Death in Mouse Optic Nerve Injury Models 
 
A. Whole-mount cleared optic nerves with axons stained with CTB-555 in 
control vs. OGT ko. 
B. Quantification of regeneration. 
C. RGC staining in flat mount retinas 
D. Quantification of RGC survival 
E. Alpha-RGC staining in whole mount retinas 






4.1 O-GlcNAc Manipulation Significantly Enhances Axon Regeneration 
through Novel Signaling Pathways 
 
 We have demonstrated for the first time that O-GlcNAc post-translational 
modifications have a dynamic and important role in axonal regeneration after injury. 
Interestingly, it appears that shifting the cellular O-GlcNAc state to one extreme or the 
other (i.e. complete lack of or an over-abundance of O-GlcNAc) can act as a switch to 
enhance regeneration through the insulin-signaling pathway (Figure 4.1). A loss of O-
GlcNAc modifications enhances regeneration through non-canonical activation of AKT-
1. Activation is mediated by the non-tyrosine receptor kinase ARK-1. Upon activation, 
our data suggests that AKT-1 mediates enhanced regeneration through glycolysis. In 
contrast, an abundance of O-GlcNAc modifications enhances regeneration through the 
SGK-1 kinase. This in turn acts on the transcription factor DAF-16/FOXO to up-regulate 
specific target genes. We further find that mitochondrial metabolism and function is 
affected suggesting that DAF-16 target genes play a role in regulating mitochondrial 
dynamics. This suggests a paradigm in which the perception of nutrients via O-GlcNAc 
levels can act as a metabolic switch in regenerating neurons. A lack of O-GlcNAc, 
conveying reduced nutrient availability, leads to the use of glycolysis for regeneration 
whereas an abundance of O-GlcNAc, conveying a nutrient abundance, leads to the use of 













Others have observed that manipulating O-GlcNAc levels in culture can alter 
axonal growth in a developmental paradigm. Culturing embryonic chicken neurons 
overexpressing the O-GlcNAcase revealed an enhancement of axonal growth and 
branching (Francisco et al., 2009). This effect was primarily due to an increased number 
of filopodia. In contrast, inhibiting the O-GlcNAcase with either PUGNAc or 9D did not 
produce any effects on axonal growth but significantly lowered the number of filopodia. 
The authors suggested that cAMP may be involved as O-GlcNAcase inhibition with 9D 
significantly inhibited the increased number of branches observed when culturing 
neurons with forskolin, a phosphodiesterase inhibitor (Francisco et al., 2009). 
 
 Another group also implicated O-GlcNAc in the cAMP pathway in axonal growth 
(Rexach et al., 2012). Cultured mouse cortical neurons depolarized with KCl exhibited an 
increase of CREB O-GlcNAcylation at Ser40, thereby repressing CREB activity. 
Interestingly, removing the O-GlcNAc Transferase resulted in increased axonal length 
whereas its overexpression significantly decreased length. 
 
 The role of cAMP and CREB in axonal regeneration is well-established in 
mammalian and C. elegans models. Elevations of cAMP lead to an enhancement of axon 
regeneration through distinct mechanisms in the two species. In mammals, CREB 
activation leads to the transcription of Arginase I and the production of polyamines (Cai 
et al., 2002). Through metabolism, polyamines are converted and lead to an unusual 




(eIF5A), which enhances its activity (He et al., 2016). This in turn is hypothesized to up-
regulate p35 translation, leading to the activation of cyclin-dependent kinase 5 (Cdk5), 
and a reversal of the inhibition on axonal growth with myelin-based inhibitors (He et al., 
2016). In contrast, C. elegans display CREB-independent enhancement of regeneration 
by cAMP. This is hypothesized to be through the activation of the CEBP-1/ETS-4 axis by 
Protein Kinase A to then activate MAPK-signaling (Li et al., 2015).  
 
 However, in our studies, the effect of O-GlcNAc on axon regeneration appears 
independent of cAMP/CREB (Figure 3.9). Loss-of-function mutation of the CREB 
transcription factor do not affect either ogt-1 or oga-1 mutants. In addition, loss-of-
function of the phosphodiesterase, producing an enhancement of cellular cAMP levels, 
did not affect axon regeneration in O-GlcNAc mutants, although the double mutants were 
not additive suggesting either we have reached a ceiling for 24-hour regeneration or that 
the two pathways interact at an unknown level. Alternatively, as C. elegans does not have 
myelination, it could be that the effects of CREB activation and polyamine synthesis are 
not conserved or that the transcriptional targets of CREB in these two species may differ.  
 
4.2 O-GlcNAc Enhances Axon Extension during a Later Stage of 
Regeneration 
 
 Axon regeneration follows distinct spatiotemporal steps: 1) membrane resealing 




cone 4) axon extension 5) re-connecting with post-synaptic targets (Figure 1.3). 
Accordingly, the function of different pathways can begin to be assessed by analyzing 
when the regeneration phenotype is most prominent. Time-lapse analysis of regeneration 
determined that O-GlcNAc mutants likely act at a late stage of axon regeneration 
between 12 and 24 hours post injury with significant axon extension phenotypes observed 
at 24 hours (Figure 3.5). Interestingly, neuronal development in the ogt-1 and oga-1 
mutants is not different from wildtypes, suggesting the impact of O-GlcNAc on axon 
extension is specific to injury and regeneration. Accordingly, early mediators of 
regeneration, such as calcium-signaling and dlk-1 signaling, were determined to be 
independent of O-GlcNAc signaling in regeneration (Figure 3.6). Examination of early 
filopodial dynamics also revealed that O-GlcNAc mutants act in a similar manner to 
wildtypes between 1 and 3 hours post injury (Figure 3.5). Interestingly, oga-1 mutants 
had reduced filopodial number at 5 hours post-injury compared to ogt-1 and wildtypes. 
This could be due to a few factors. Often during regeneration, as in development, one 
major neurite is chosen to be the future presumptive axon and grows further than the rest 
of the other neurites. It could be that oga-1 mutants select this presumptive axon sooner 
than wildtypes and repress filopodial dynamics earlier than wildtypes do. Alternatively, 
affinity purification coupled with mass spectrometry of heavily O-GlcNAcylated proteins 
in whole C. elegans and mammals have identified actin, certain actin binding proteins, 
and alpha-tubulin(Alfaro et al., 2012; Rahman et al., 2010). These are all important 





 Other aspects of the regeneration in O-GlcNAc mutants also appeared 
indistinguishable from wildtypes. Branching and anterior vs. posterior growth direction 
are not different from wildtype (Figure 3.5). This indicates that the numbers of 
branches/neurites are not different but that the growth of each neurite is longer in the ogt-
1 and oga-1 mutants. As a whole, our data suggest that O-GlcNAc acts specifically 
during axon extension to enhance regeneration after injury.  
 
4.3 O-GlcNAc Acts Cell Intrinsically to Enhance Axon Regeneration 
 
As the effects of constitutive mutants are throughout the whole organism, we 
probed whether O-GlcNAc manipulation enhances regeneration in a cell-intrinsic or 
extrinsic manner. O-GlcNAc has been suggested previously to modify p27kip1, a cyclin-
dependent kinase inhibitor, in astrocytes and lead to enhanced astrocyte migration and 
functional and histological improvement after a spinal cord contusion in rats (Mao et al., 
2015). However, the majority of this study was conducted by mutating the serine that is 
O-GlcNAcylated to alanine resulting in a mutant than can neither be O-GlcNAcylated or 
phosphorylated. Whether the effects are due to phosphorylation, O-GlcNAcylation, or 
some complex interplay cannot be properly interpreted. In addition, no direct 
manipulation of O-GlcNAc in vivo was conducted. Regardless, the possibility that O-
GlcNAc could act within neurons to improve functional recovery compelled us to 
examine where O-GlcNAc acts. To address this, we utilized a mechanosensory-neuron 




neurons but RNAi resistance in all other tissues. When treated with ogt-1 and oga-1 
mechanosensory-neuron specific RNAi, the axon regeneration was akin to that of the 
constitutive mutants (Figure 3.3). This strongly suggests the effect is cell-intrinsic. Future 
studies combining cell-specific rescues and mutagenesis could delineate the regions of 
the ogt-1 and oga-1 genes important for regeneration.  
  
4.4 O-GlcNAc is a Nutrient-Responsive Post-Translational Modification in C. 
elegans 
 
The O-GlcNAc modification is derived from glucose through the hexosamine 
biosynthetic pathway. It has been estimated that 2-5% of cellular glucose is directed into 
the hexosamine biosynthetic pathway and that the levels of cellular glucose can change 
the levels of protein O-GlcNAcylation. To assess whether O-GlcNAc is a nutrient-sensor 
in our system, we treated C. elegans with varying concentrations of glucose and 
measured the effect on O-GlcNAcylation. We found that treatment with 100mM glucose 
was sufficient to elevate levels of O-GlcNAc to the extent of the oga-1 mutant (Figure 
3.7). However, our analysis was conducted in whole C. elegans lysates in order to obtain 
enough protein for quantitative western blotting. The actual O-GlcNAc levels in a neuron 
in normal, injured, and regenerating settings could be different and dynamic. Future 
studies will address this by examining the levels of glucose and O-GlcNAc using FRET-
sensors in a single ALM neurons during a regenerative response. A previous study found 




affected fertility, was 250mM with a toxic threshold of 333mM (Mondoux et al., 2011). 
In addition, these concentrations facilitated an increase in O-GlcNAcylation. Our 
observations are conducted well below this toxic threshold and therefore, glucose toxicity 
is not a factor in our analysis.  
 
To assess whether glucose levels affected regeneration, we treated wildtype, ogt-
1, and oga-1 mutants with either 100mM glucose or 1mM phloretin, a glucose transport 
inhibitor. Interestingly, we found that the treatment of wildtype C. elegans with glucose 
significantly enhanced regeneration to an extent comparable to oga-1 mutants (Figure 
3.2). Further, treatment of oga-1 mutants with 100mM glucose did not have an additive 
effect on regeneration. Treatment of wildtypes with the glucose transporter inhibitor did 
not affect regeneration, as expected, but significantly decreased regeneration in oga-1 
mutants. This is expected as O-GlcNAc synthesis is dependent on glucose levels. We also 
found that treatment with the glucose transport inhibitor reduced ogt-1 mutant 
regeneration (discussed further below). Taken together, this suggests that elevations of 
glucose produce elevations in O-GlcNAc levels leading to enhanced regeneration, akin to 
what is occurring in the oga-1 mutant background.  
 
Glucose was specifically advantageous for enhancing wildtype regeneration but 
does not appear essential, as wildtype regeneration remains unaffected by the glucose 
transport inhibitor. This is in accordance with a recent study (and this work) showing that 




2016) and suggests that while glucose utilization is not essential, it can be up-regulated to 
enhance the growth process. This will be elaborated on in a later section.  
 
 
4.5 O-GlcNAc Acts through the Insulin-Signaling Pathway to Enhance Axon 
Regeneration 
 
 We screened many pathways important in axon regeneration to determine the 
genetic epistasis between these and the O-GlcNAc mutants to begin to determine the 
molecular underpinnings of the enhanced regeneration. Although O-GlcNAc has been 
implicated in calcium and cyclic AMP signaling in other settings, we did not find that the 
O-GlcNAc mutants depended on these pathways. Instead, we identified that the O-
GlcNAc mutants depend on the insulin-signaling pathway to enhance regeneration. 
Genetic epistasis analysis between loss-of-function mutants in the insulin-signaling 
pathway revealed that the O-GlcNAc mutants differentially relied on specific kinases to 
mediate regenerative outgrowth. The ogt-1 mutants specifically relied on akt-1, whereas 
the oga-1 mutants relied on the parallel kinase, sgk-1 (Figure 3.10 and 3.14).  
  
The insulin-signaling pathway has previously been implicated in both axon 
regeneration and O-GlcNAc signaling in C. elegans. Insulin receptor/daf-2 mutants were 
found to have enhanced regeneration in day 5 adults in the GABAergic motor neurons 




FOXO transcription factor DAF-16, similar to DAF-2’s effect on longevity. Examination 
of DAF-16 targets by ChIP-seq revealed DLK-1 in the MAPK-signaling pathway to be a 
target and important in age-related regeneration (Byrne et al., 2014). 
 
In addition, O-GlcNAc mutants were previously found to have altered lifespans 
with ogt-1 and oga-1 mutants living modestly shorter and longer, respectively (Love et 
al., 2010; Rahman et al., 2010). As insulin-signaling is one of the major pathways 
controlling aging in C. elegans, its involvement was tested in O-GlcNAc mutants. 
Mutations in daf-16 produced no effect on ogt-1 mutant lifespan but did significantly 
decrease oga-1 mutant longevity(Rahman et al., 2010). Epistasis analysis between other 
genes in the insulin-signaling pathway was inconclusive and many genes including akt-1 
and akt-2 remained untested. Interestingly, they did find that oga-1 mutations are able to 
suppress daf-2 mediated lifespan suggesting that oga-1 is acting downstream of daf-2 but 
upstream of daf-16 in longevity, similar to our observations in regeneration(Rahman et 
al., 2010). Another study examined O-GlcNAcylation with respect to the stress response 
and dauer. The authors found that O-GlcNAc can modify promoter regions of DNA that 
encode for stress-related genes including PIP3 interacting proteins and 14-3-3 proteins, 
both of which are known to intersect with the insulin-signaling pathway (Love et al., 
2010). The authors also found that daf-16 itself had promoter segments that were 
modified by O-GlcNAc. In addition to similar findings on aging, they found that oga-1 
mutants were better able to handle stress by modifying insulin signaling. Again, lack of 




GlcNAc is acting at the transcriptional or protein level. Our findings shed light onto these 
studies. Our in-depth epistasis analysis of each gene in the insulin signaling pathway 
revealed the requirement of the intermediate kinases akt-1 and sgk-1. This is likely to 
occur at the protein level as neither akt-1 or sgk-1 promoters are O-GlcNAcylated in C. 
elegans. Further, several studies have found that AKT1 is O-GlcNAcylated in mammals 
(Vosseller et al., 2002).   
 
4.6 Activated CDC42 Non-Receptor Tyrosine Kinase/ark-1 is a Novel 
Component of the Insulin-Signaling Pathway in C. elegans 
 
 While the phosphoinositide 3-kinase (PI3K), age-1, is the canonical upstream 
activator of akt-1, we interestingly found that this was not the case in ogt-1 mutant 
regeneration. A similar phenomenon has also been observed in mammalian systems in 
which AKT is activated in a PI3K-independent manner (Mahajan et al., 2010). AKT 
activation follows discrete steps in which an inactive cytosolic protein is recruited to the 
plasma membrane upon increased PI3K activity. This is due to the action of PI3K to 
convert PIP2 to PIP3, which recruits AKT via its plextrin homology domain. Upon 
binding to PIP3, AKT becomes able to interact with other interacting factors, notably 
PDK and mTORC, and is phosphorylated at Thr308 and Ser473. Phospho-AKT is then 
active and can phosphorylate downstream targets. Activity can also be extinguished by 
certain phosphatases, notably PP2A. In contrast to this canonical mechanism of 




tyrosine phosphorylation of Akt1 at Tyr176 (Mahajan et al., 2010). This phosphorylation 
event alone was able to recruit AKT to the membrane for further activation. Treatment 
with a PI3K inhibitor did not abolish this effect and further studies identified that this 
phosphorylation is due to the action of the Activated CDC42 Non-Receptor Tyrosine 
Kinase (ACK). We conducted a homology search and found that the C. elegans gene ark-
1 is roughly 88% similar at the amino acid level. In addition, a loss-of-function mutation 
in this gene significantly reduced ogt-1 regeneration (Figure 3.11). Using a gain-of-
function allele of akt-1, we further demonstrated that it can restore the ogt-1;ark-1 double 
mutant regeneration to that of ogt-1 levels. This demonstrates that in our system, ark-1 is 
genetically upstream of akt-1 and is necessary for akt-1 activation.   
 
 This also demonstrates a new potential role for ACK/ark-1 in the context of 
axonal injury. While loss of ark-1 function alone does not affect regeneration, it is clear 
that its activation can have a beneficial role in mediating akt-1 activity. ACK has been 
previously implicated in various cancers and in the dynamics of endocytosis (Wu et al., 
2015; Wu et al., 2017; Yoo et al., 2004). In terms of cancer, ACK expression correlates 
with aggressive phenotypes in breast cancer and its knockdown significantly suppresses 
tumor growth in a rodent xenograft model (Wu et al., 2015). However, much is unknown 
about ACK signaling dynamics and targets. The ACK structure is divided into a N-
terminal sterile-alpha motif and kinase domains, followed by an SH3 domain, a CRIB 
domain, a C-terminal proline-rich EGFR-binding domain and a ubiquitin associated 




growth factor receptor-bound protein 2 (Grb2), an adapter protein. Activated growth 
factor receptor tyrosine kinases can bind Grb2 via its SH2 domain. ACK can then bind to 
Grb2’s SH3 domain via its proline-rich C-terminal domain. Upon activation, ACK then 
proceeds to phosphorylate target tyrosines. A new study suggests that ACK can also have 
a role in the nucleus in governing histone dynamics (Mahajan et al., 2017). In a model of 
castration-resistant prostate cancer, the androgen receptor can recruit ACK to the 
androgen receptor promoter and phosphorylate Tyr88 of histone 4. This leads to the 
recruitment of the MLL2/WDR5 chromatin remodeling complex and a persistent 
activation of androgen receptor targets. Gene enrichment analysis found that these targets 
include cancer-related gene signatures involved in DNA-repair, proliferation, E2F, MYC, 
and estrogen-receptor targets. Therefore, whether ACK acts at the transcriptional level to 
regulate these pro-growth pathways in axon growth and regeneration is an interesting 
question. This could be examined by performing immunoprecipitation to see if ACK 
interacts with and phosphorylates histone 4 in mature neurons and during axon growth. 
 
 ACK is expressed in the developing mouse and rat brain although its function is 
unknown (La Torre et al., 2006; Urena et al., 2005). Northern blots revealed that ACK 
mRNA is upregulated throughout developmental time, peaking at the adult stage. In situ 
hybridization showed expression in the hippocampus, cortex, and cerebellum, although a 
moderate level of expression was detected throughout other brain regions (La Torre et al., 
2006; Urena et al., 2005). Hippocampal neuronal cultures determined the localization of 




2017). However, genetic lesions of ACK in mice have not been performed. Given our 
results in C. elegans, whether or not a neurological phenotype exists in 
knockout/overexpression mouse models is an interesting area for future research. 
Likewise, whether the role of O-GlcNAc and ACK/ark-1 in axon growth and 
regeneration is conserved is a key question for future studies. Mass spectrometry of 
mouse brains revealed that ACK is O-GlcNAcylated at T832 and T833, which lies in the 
proline-rich EGFR binding domain (Alfaro et al., 2012). O-GlcNAcylation of these 
residues may therefore inhibit the interaction of ACK with EGFR or result in an overall 
conformational change that impairs Grb2 interaction.  
 
4.7 Glycolysis is Important for ogt-1 Mutant Regeneration 
 
Unexpectedly, we found that like the oga-1 mutants, treatment of the ogt-1 
mutants with the glucose transport inhibitor phloretin significantly suppressed 
regeneration (Figure 3.2). This suggested that the regenerative response was dependent 
on glucose utilization. O-GlcNAc C. elegans mutants have been previously implicated in 
glucose metabolism and utilization. Whole animal lysates revealed that both ogt-1 and 
oga-1 mutants have increased levels of glycogen and trehalose and decreased levels of 
triacylglycerol (Forsythe et al., 2006). This is enigmatic in that if ogt-1 mutants were 
utilizing glucose at higher rates, they might be expected to have lower glycogen stores. 
However, there may be differences between organismal and cellular metabolism. In 




enabling glycolysis remains a possibility. Evidence in mammalian hypoxic tumor cell 
line suggests that O-GlcNAc can act as a switch between glycolysis and the pentose 
phosphate pathway with a lack of O-GlcNAcylation supporting glycolysis (Yi et al., 
2012). The glycolytic enzyme phosphofructokinase-1 is modified by O-GlcNAc at 
Ser529. Over-expression of OGT, and therefore enhancing O-GlcNAc levels, results in a 
decrease in the glycolytic rate. This effect is abolished when Ser529 is mutated 
suggesting that O-GlcNAcylation at this residue is important for controlling glycolytic 
flux. This residue is conserved in C. elegans and whether or not this is important in ogt-
1/oga-1 mutant regeneration is unknown. However, given that the regeneration is 
dependent on insulin-signaling, it is unlikely that the modification of a glycolytic enzyme 
alone that enhances regeneration. Given that the regeneration of ogt-1 mutants is 
dependent on akt-1, a kinase known to be involved in a number of metabolic pathways, 
we screened a number of pathways downstream of AKT to begin to establish how 
regeneration is enhanced mechanistically in ogt-1 mutants. While FOXO/daf-16, mTOR, 
and GSK-3 were negative, we found an important role for glycolysis, agreeing with our 
findings above. Inhibition of glycolysis, but not oxidative phosphorylation, produced a 
specific decrease in ogt-1 mutant regeneration. AKT is a well-known mediator of 
metabolic flux and is a key player in cancer cells using glycolysis even in oxygen 
permissive conditions, known as the Warburg effect (Ward and Thompson, 2012). AKT 
can enable this by acting directly and indirectly (Robey and Hay, 2009). Direct 
phosphorylation of glycolytic enzymes, hexokinase and phosphofructokinase, by AKT 




protein effectors of metabolism such as mTOR (Memmott and Dennis, 2009). Further, 
AKT could have indirect effects on transcription of metabolic genes. For example, AKT 
is a negative regulator of p53 and MDM2, which are known tumor-suppressors (Gottlieb 
et al., 2002). AKT activation therefore inhibits p53’s regulation of glycolysis by releasing 
the transcriptional block in glycolytic genes like hexokinase, phosphoglycerate mutase, 
and glucose transporters. As C. elegans lacks homologs of p53 and MDM2 and we have 
ruled out mTOR and GSK-3, we favor a model in which AKT directly influences 
glycolytic enzymes. Further, we have shown inhibiting glycolytic enzymes represses ogt-
1 mutant regeneration. Examining whether this occurs in C. elegans and mammalian 
neurons after damage will be important to address. Future work utilizing glucose FRET 
sensors in C. elegans may demonstrate increased glucose utilization upon injury. 
However, a detailed analysis requires examining glycolysis in mouse neuronal cultures 
before and after injury and examining the involvement of AKT. Mass spectrometry could 
identify residues of specific glycolytic enzymes that are phosphorylated by AKT and 
these residues can then be mutated and examined functionally.  
 
4.8 OGT Inhibition Enhances the Regenerative Response in Injured 
Mammalian Cortical Neurons in vitro but not in vivo 
 
To examine if our findings in C. elegans translated into a mammalian system, we 
first determined whether inhibition of OGT using the pharmacological inhibitor 




cortical neurons. We found that by 6 hours after injury the number of axons with growth 
cones, structures indicating new axonal growth, was significantly elevated in OGT 
inhibitor treated neurons while axon growth trended upward but did not reach 
significance. Other studies have examined axon regeneration in cultured neurons over a 
24-hour period with growth cone structures appearing 1 to 6 hours after injury and axonal 
extension occurring later. We hypothesize that looking at later time-points in 
regeneration, optimizing dose and timing of treatment may be beneficial in enhancing 
this regenerative response.  
 
 Given these encouraging initial results, we examined the effect of OGT inhibition 
in an in vivo mouse model of axon regeneration. Surprisingly, we found that genetic 
ablation of OGT had no or a mild effect on regeneration. Further, retinal ganglion cell 
(RGC) cell death was significantly elevated in OGT ablated mice. While this is in stark 
contrast to what we observe in our C. elegans and cell culture model, others have 
observed cell death in OGT ablated sensory neurons in mice (Su and Schwarz, 2017). 
Why does OGT ablation cause cell death in this model? Previous work has suggested that 
many types of neurons are developmentally glycolytic but then rely on mitochondrial 
oxidative phosphorylation for energy generation once mature (Zheng et al., 2016). 
Whether this is the case for retinal ganglion cells is unknown but many forms of inherited 
disease of RGCs stem from mutations in mitochondrial metabolism, highlighting its 
importance (Ito and Di Polo, 2017).  If our model is correct, then ablating OGT and 




machinery is present, may induce an energy crisis and cell death. In contrast, in our cell 
culture model, the neurons are still developmentally primed (isolated at E18.5) and have 
access to excess glucose in the culture media. Alternatively, the role of O-GlcNAc may 
not be evolutionarily conserved. However, our preliminary results in culture suggest that 
under the right conditions, enhancement of regeneration by knocking down OGT may be 
beneficial.  
 
4.9 Serum Glucocorticoid Kinase (sgk-1) is Important for oga-1 Mutant 
Regeneration 
 
 The regeneration of oga-1 mutants did not rely on age-1, akt-1, or akt-2. Through 
epistasis experiments, we interestingly found that oga-1 acted downstream of daf-2 and 
upstream of daf-16 (Figure 3.13). A lesser known kinase in the insulin-signaling pathway 
that fit these criteria is the serum glucocorticoid kinase, sgk-1. Loss-of-function of this 
kinase specifically inhibited oga-1 regeneration while leaving wildtypes unaffected. The 
role of sgk-1 in the insulin-signaling pathway is less defined than the other components. 
In terms of lifespan, the predominant phenotype of insulin-signaling mutants, sgk-1 
mutants have been contradictorily reported to have lowered or enhanced lifespan. In an 
assessment of the genetic components underlying the enhanced lifespan of O-GlcNAc 
mutants, the authors observed a moderate enhancement of lifespan in sgk-1 mutants 




mutations in an sgk-1 mutant background had no effect on lifespan, suggesting the two 
are potentially acting in a similar pathway in lifespan (Rahman et al., 2010).  
 
 Previous studies have demonstrated that sgk-1 can act on the DAF-16 
transcription factor to upregulate specific DAF-16 target genes. SGK-1 can directly 
phosphorylate DAF-16 in vitro but the consequences of this phosphorylation remain 
unclear (Hertweck et al., 2004). Others have suggested that this interaction either alone or 
in combination with other factors allows the regulation of a subset of DAF-16 target 
genes (Chen et al., 2013). Analysis of DAF-16 target genes regulated by AKT-1 and 
SGK-1 revealed an important disparity, suggesting that SGK-1 acts on DAF-16 in a more 
complex way than previously recognized (Chen et al., 2013). We favor a model in which 
the activation of sgk-1 can result in the regulation of a subset of DAF-16 genes that are 
important for the regenerative response seen in oga-1 mutants. While our genetic 
epistasis data supports this, a more detailed biochemical evaluation is required. Further, 
examining expression levels of subsets of DAF-16 target genes and subsequently 
knocking down genes which are regulated by SGK-1 may be fruitful in understanding the 
interaction between SGK-1, DAF-16, and regeneration.  
 
Further, whether SGK-1 itself is O-GlcNAcylated or there remains a missing 
interacting protein is unclear. Previous mass spectrometry studies have not identified 
SGK1 as an O-GlcNAcylated protein (Alfaro et al., 2012). However, these studies have 




this may play a functional role in insulin-signaling (Whelan et al., 2010). Upon insulin 
stimulation of 3T3-L1 adipocytes, PDK1 and OGT interact and PDK1 O-GlcNAcylation 
occurs. This is proposed to inhibit insulin-signaling, potentially at the level of AKT. 
Activation of SGK can occur through PDK1. Therefore, O-GlcNAc modification of 
PDK-1 may lead to SGK-1 activation (Whelan et al., 2010). Alternatively, it has been 
proposed in C. elegans that AKT-1, AKT-2, and SGK-1 form a complex (Hertweck et al., 
2004).O-GlcNAcylation of one or more of these components leading to alterations in 
complex constituents or activity could be a potential mechanism of balancing AKT vs. 
SGK activation.   
 
4.10 O-GlcNAcase (oga-1) Mutants have a Global Effect on Mitochondrial 
Function 
 
Both DAF-16 and O-GlcNAc have been heavily implicated in altering 
mitochondrial function. As a transcription factor, DAF-16 regulates a number of 
mitochondrial genes. For example, upon oxidative stress, DAF-16 up-regulation of the 
superoxide dismutase 3 (SOD-3) to mitigate oxidative damage is a well-known example 
(Chavez et al., 2007). However, a statistical analysis of DAF-16 targets shows no over-
representation of mitochondrial genes. Further, mechanosensory neuron-specific targets 
of DAF-16 reveal a completely different set of genes compared with whole C. elegans 
lysates (Kaletsky et al., 2016). In this case, the number of genes with mitochondrial 




functions such as synaptic transmission. Whether the effect of DAF-16 on mitochondria 
is therefore direct or indirect remains to be seen.  
 
 Regardless, DAF-16 has several effects on mitochondria. First, DAF-16 over-
expression or DAF-2 mutation resulting in DAF-16 activation results in enhanced 
oxidative stress resistance (Tullet et al., 2017). DAF-16 has been proposed to accomplish 
this by the regulation of SOD-3 and metallothionein-1 (MTL-1), a key metal-binding 
protein involved in the stress response. However, transcriptomes of the mechanosensory 
neurons show that sod-3 is not expressed (Kaletsky et al., 2016). Further, we have shown 
that RNAi against mtl-1 has no effect on oga-1 regeneration suggesting it is also not 
involved. Exactly how DAF-16 is able to achieve a reduced oxidative environment in 
neurons is unknown. Second, DAF-16 is implicated in mitochondrial motility, although 
the exact role is unknown. Mitochondrial motility declines with age in ALM neurons and 
this can be prevented by daf-2 loss-of-function or dietary restriction via eat-2 mutation 
(Morsci et al., 2016). Our study is another example, and excellent model, to assess the 
effect of DAF-16 on mitochondrial function given that we can monitor multiple aspects 
of mitochondrial function at a single cell level. We plan to interrogate this further with 
the help of neuron specific RNAi. 
 
 Akin to DAF-2/DAF-16 genetic lesions, O-GlcNAc modifications have also been 
shown to impact mitochondrial function. At the organelle level, O-GlcNAc 




organized cristae (Tan et al., 2017). The consequences of these morphological alterations 
are not understood but several mitochondrial phenotypes have been observed. O-GlcNAc 
overexpression is protective against oxidative stress and heat-shock and this is dependent 
on GSK-3beta, HIF1, and heatshock proteins (Zachara et al., 2004). Further, respiration 
in these mitochondria is blunted (Tan et al., 2017). Finally, mitochondrial motility is 
affected by O-GlcNAc level through post-translational modification of mitochondrial 
motor adapter proteins. High O-GlcNAc levels, and therefore high O-GlcNAc 
modification of the mitochondrial motor adapter protein Milton, results in less motile 
mitochondria (Pekkurnaz et al., 2014).  
 
 We also observed effects of high O-GlcNAc levels on mitochondrial function 
(Figure 3.17). Oxidative stress resistance, mitochondrial respiration, and mitochondrial 
motility were all affected in oga-1 mutant regeneration. The mitochondrial motility 
phenotype is particularly interesting. Motility has been previously linked to regenerative 
potential. Armcx1 is a mitochondria-localized protein which plays a key role in 
governing motility. Overexpression of Armcx1 results in enhanced motility and enhanced 
regenerative outgrowth (Cartoni et al., 2017). Further, increased mitochondrial motility 
correlates well with regenerative capacity of axons after injury (Cartoni et al., 2017; Han 
et al., 2016). This also appears to be conserved in C. elegans models. Knocking down the 
key mitochondrial motor adaptor complex protein miro-1, decreased mitochondrial 
abundance in the regenerating axon and regenerative outgrowth whereas overexpression 




(Han et al., 2016). However, in our oga-1 mutants that have increased regenerative 
outgrowth, mitochondrial motility is substantially reduced (Figure 3.17). This suggests 
that while motility is helpful for enhanced regeneration, it may not be necessary and other 
mitochondrial phenotypes, such as oxidative stress resistance, may be more important.  
 
 The role of oxidative stress in axon growth is still underexplored. While excess 
levels of reactive oxygen species (H2O2, O2-, and HO+) are clearly detrimental through 
irreversible damage of proteins and lipids, some optimal level may be important. In 
particular, the cytoskeleton is sensitive to the oxidative environment. Actin 
polymerization is inhibited by oxidative environments and some studies have suggested 
that a redox balance is necessary for proper growth cone formation and axon outgrowth 
(Wilson and Gonzalez-Billault, 2015). Our study suggests that the ability to maintain a 
reduced environment is key for regeneration (Figure 3.16). If regenerating axons of oga-1 
mutants are predominantly utilizing mitochondrial metabolism, then keeping a reductive 
environment may be beneficial.  
 
From the list of genes regulated by DAF-16 in mechanosensory neurons, we 
identified a subset of metabolic and/or mitochondrial genes. However, RNAi against 
these genes did not impact oga-1 regeneration (Figure 3.18). Exactly how OGA-1 and 
DAF-16 act to alter global mitochondrial dynamics remains unclear. Given that OGA-1 
mutants appear to alter mitochondrial dynamics as a whole, as opposed to one aspect of 




acting on a global regulator of mitochondrial function such as a transcription factor. 
Examination of DAF-16 target genes that have mitochondrial functional annotation and 
are transcription factors identify only one, MEX-6, the C. elegans homolog of 
tristetraprolin. This is particularly interesting because tristetraprolin has been implicated 
in mitochondrial function. Overexpression of tristetraprolin results in elongated 
mitochondria, reduced mitochondrial membrane potential, decreased ATP production, 
and increased reactive oxygen species production (Vo et al., 2017). While some of these 
phenotypes match the oga-1 mutants, others are opposites. This could be due to the 
experimental system used or the distant homology (~17% conservation). If MEX-6 is 
involved, then knocking down mex-6 should suppress the regeneration observed in oga-1 
mutants and be redundant with daf-16.   
 
Alternatively, DAF-16 could be regulating numerous mitochondrial genes in 
parallel. DAF-16 regulates 12 genes, which we have identified, that have annotated 
mitochondrial function with functions that range from maintaining the mitochondrial 
membrane potential to oxidative stress resistance. Additive mutants/RNAi should be able 
to distinguish whether this is a possibility in the future.  
 
4.11 Metabolism of Injured and Regenerating Neurons 
 
 Ultimately, our results suggest that certain metabolic pathways are more 




focused on the important role of mitochondria, as discussed above. Experiments in C. 
elegans have begun to delineate a role for not only mitochondrial motility and density, 
but also components of the electron transport chain as having roles in regeneration. 
Interestingly, components of complex I (gas-1, nduf-2.2, nduf-7) and complex II/III (rad-
8 and isp-1) were identified as important for regeneration while components of complex 
II, III, Ubiquinone, and the ATP Synthase were found to be non-essential. Oddly, only 
certain components in each complex were important (Knowlton et al., 2017). For 
example, in complex I, nduf-2.2 mutants displayed reduced regeneration whereas nuo-6 
mutants did not even though they both have deficits in ATP synthesis. This discrepancy 
may be due to the severity of each loss-of-function mutation (as complete loss-of-
function of these components are lethal) or the neuronal subtypes analyzed. Interestingly, 
overexpression of only nduf-2.2 and isp-1, is able to enhance regeneration whereas the 
others are unable (Knowlton et al., 2017). This suggests a dose-dependent effect for some 
of these components as well. The above results were obtained in the Posterior Lateral 
Microtubule (PLM) neuron or the motor neurons. My results in the Anterior Lateral 
Microtubule (ALM) neuron suggest that nduf-2.2 knockdown via RNAi or nuo-6 genetic 
loss-of-function have no impact on wildtype regeneration suggesting neuronal subtype is 
indeed important. 
 
 Our results also reveal the previously underappreciated role of glycolytic 
metabolism in axon growth. Whether neurons utilize glycolysis, mitochondrial oxidative 




highly debated and may be neuronal subtype or species dependent. However, recent 
advances made in metabolic imaging using FRET-based biosensors have revealed an 
important role for neuronal glycolytic metabolism during neuronal stimulation or periods 
of energy stress. In C. elegans, neuronal stimulation leads to the formation of clusters of 
glycolytic enzymes at synapses and this is essential to power the synaptic cycle (Jang et 
al., 2016). Further, glycolytic enzymes, but not mitochondrial oxidative phosphorylation, 
were essential to sustain synaptic activity under high neuronal stimulus regimes. In 
mouse models, a similar picture is emerging. Previous models have suggested that upon 
neuronal stimulation, glutamate is released and triggers glucose metabolism in astrocytes. 
The lactate produced by the astrocytes could then be shuttled to neurons for ATP 
production through mitochondrial oxidative phosphorylation (Pellerin et al., 2007). This 
data was supported by the relatively high levels of expression of glycolytic enzymes in 
astrocytes and low levels in neurons coupled with metabolic measurements made in cell 
culture models (Pellerin and Magistretti, 1994; Zhang et al., 2014). However, FRET-
based biosensors in vivo and in cultured hippocampal slices have suggested that under 
stimulation, neurons are largely glycolytic whereas basal metabolism is mitochondrial 
(Diaz-Garcia et al., 2017). Future efforts to examine these discrepancies should provide 
fruitful information into the metabolic allotment of neurons.  
 
 Our data in ogt-1 mutants is in line with neurons utilizing glycolysis under 
conditions of energy stress (i.e. neuronal injury and regeneration). Why is this source of 




glycolysis is lower than oxidative phosphorylation, it can occur at much faster rates 
(Pfeiffer et al., 2001). This may be advantageous during an injury as energy is needed 
rapidly to mitigate damage and enable regrowth. Our work demonstrates that glycolysis, 
as well as finding other mutants that enhance glycolysis, may be key to optimizing 
regrowth. As many of the glycolytic enzymes are controlled allosterically by metabolic 
products, finding therapeutics that lock glycolytic enzymes into an active conformation 
may also be an interesting avenue.  
 
4.12 Concluding Remarks 
 The regeneration of damaged axons remains a key goal in regenerative medicine. 
Our results demonstrate a unique mechanism by which O-GlcNAc post-translational 
modifications can orchestrate the metabolic response after injury to improve 
regeneration. We hypothesize that O-GlcNAc levels may interpret cellular nutrient status 
and act as a switch governing either glycolytic or mitochondrial metabolism. In the case 
of ogt-1 mutants, a perceived absence of nutrients (i.e. low glucose) may trigger glucose 
metabolism to create more of the O-GlcNAc moiety. In contrast, in the oga-1 mutants, a 
perceived abundance of nutrients (i.e. high glucose) triggers mitochondrial oxidative 
phosphorylation. This is accomplished by a dueling-kinases scenario where low O-
GlcNAc activates AKT, whereas high O-GlcNAc activates SGK. Whether this model is 
conserved across neuronal injury models and whether this can be therapeutically targeted 








Appendix 1: Strains Used and Sample Sizes 
Gene Name Allele(s) Used Strain Name N 
WT (zdis5 pmec-4::GFP)   SK4005 40 
ogt-1 ok1474 RB1342 40 
oga-1 ok1207 RB1169 40 
daf-2 e1370 CB1370 17 
ogt-1;daf-2   CG121 22 
oga-1;daf-2   CG122 20 
age-1 hx546 TJ1052 18 
ogt-1;age-1   CG123 21 
oga-1;age-1   CG124 11 
akt-1 ok525, mg144 
RB759, 
GR1310 20, 18 
akt-1(ok525)     18 
ogt-1;akt-1(ok525)   CG125 17 
oga-1;akt-1(ok525)   CG126 20 
akt-1(mg144)     16 
ogt-1;akt-1(mg144)   CG127 18 
oga-1;akt-1(mg144)   CG128 10 
sgk-1 ok538 VC345 13 
oga-1;sgk-1   CG129 15 
ark-1 sy247 PS1461 15 
ogt-1;ark-1   CG130 29 
ogt-1;ark-1;akt-1(mg144)   CG131 21 
ogt-1;ark-1;akt-1(ok525)   CG132 17 
daf-16 mu86 CF1038 14 
ogt-1;daf-16   CG133 19 
oga-1;daf-16   CG134 17 
akt-2 ok393 VC204 23 
ogt-1;akt-2   CG135 25 
pfk-1.1 ola72 DCR3791 20 
ogt-1;pfk-1.1   CG136 18 




ogt-1;nuo-6   CG137 16 
ogt-1;itr-1 sa73 N/A 13 
pde-4 ce268 KG744 20 
ogt-1;pde-4   N/A 20 
oga-1;pde-4   N/A 20 
crh-1 tz2 YT17 20 
ogt-1;crh-1   N/A 19 
oga-1;crh-1   N/A 20 
PLM Neuron       
WT (zdis5 pmec-4::GFP)     19 
ogt-1     30 
oga-1      10 
        
MitoROGFP Oxidative Stress        
Uncut       
pha-1(e2123); him-5(e1490); 
zhsEx17[Pmec-4mitoLS::ROGFP]   PTN73 15 
oga-1; pha-1(e2123); him-5(e1490); 
zhsEx17[Pmec-4mitoLS::ROGFP]   CG138 15 
Cut       
pha-1(e2123); him-5(e1490); 
zhsEx17[Pmec-4mitoLS::ROGFP]   PTN73 15 
oga-1; pha-1(e2123); him-5(e1490); 
zhsEx17[Pmec-4mitoLS::ROGFP]   CG138 15 
        
DAF-16::GFP Localization       
Non-heatshocked       
muIs61 [(pKL78) daf-16::GFP + rol-
6(su1006)]; daf-16 (mu86)   CF1139 20 
oga-1; muIs61 [(pKL78) daf-16::GFP 
+ rol-6(su1006)]; daf-16 (mu86)   CG139 24 
Heatshocked       
muIs61 [(pKL78) daf-16::GFP + rol-
6(su1006)]; daf-16 (mu86)   CF1139 14 
oga-1; muIs61 [(pKL78) daf-16::GFP 
+ rol-6(su1006)]; daf-16 (mu86)   CG139 11 




GSK-3b Overexpression       
Non-heatshocked       
(phsp16.2::gsk-3b;pmec-7::GFP)   KN131 20 
ogt-1; (phsp16.2::gsk-3b;pmec-
7::GFP)   CG140 18 
Heatshocked       
(phsp16.2::gsk-3b;pmec-7::GFP)   KN131 22 
ogt-1; (phsp16.2::gsk-3b;pmec-
7::GFP)   CG140 20 
WT zdis5    SK4005 15 
        
Drug Treatments       
WT zdis5 (DMSO)   SK4005 7 
WT zdis5 (Rapamycin)     10 
daf-18 (DMSO) ok480 RB712 10 
daf-18 (Rapamycin)     16 
ogt-1 (DMSO) ok1474 RB1342 6 
ogt-1 (Rapamycin)     11 
WT zdis5 (100mM D-mannitol)     19 
WT zdis5 (100mM glucose)     27 
WT zdis5 (1mM phloretin)     18 
WT zdis5 (5mM 2-deoxy-D-glucose)     20 
WT zdis5 (10mM 2-deoxy-D-
glucose)     20 
ogt-1 (100mM glucose)     19 
ogt-1 (1mM phloretin)     14 
ogt-1 (5mM 2-deoxy-D-glucose)     21 
ogt-1(10mM 2-deoxy-D-glucose)     15 
oga-1 (100mM glucose)     12 
oga-1(1mM phloretin)     17 
WT zdis5 (EtOH controls for 
Thiamet G)     19 
WT zdis5 (2uM Thiamet G)     20 
oga-1 (2uM Thiamet G)     19 
WT zdis5 (DMSO controls for 
ST045849)     19 




ogt-1 (50uM ST045849)     18 
WT (7.5mM EGTA)     11 
ogt-1 (7.5mM EGTA)     15 
        
RNAi        
GFP Vector Control     10 
GFP RNAi     9 
Vector Control WT TU3568     21 
ogt-1 RNAi     13 
oga-1 RNAi     15 
nduf-2.2 RNAi     14 
OGT-1 RNAi Targets       
ogt-1;TU3568 Vector     9 
glt-1 RNAi     10 
fgt-1 RNAi     14 
swt-7 RNAi     13 
mct-2 RNAi     8 
mct-4 RNAi     9 
mct-5 RNAi     9 
mct-6 RNAi     23 
aat-9 RNAi     21 
ZK829.9 RNAi     12 
pgk-1 RNAi     23 
nduf-2.2 RNAi     18 
OGA-1 RNAi Targets       
oga-1; TU3568 Vector     19 
nduf-2.2 RNAi     22 
Timelapse Dynamics       
WT zdis5       
1 hr     17 
3 hr     17 
5 hr     17 
12 hr     16 
24 hr     40 
ogt-1       
1 hr     21 




5 hr     21 
12 hr     22 
24 hr     40 
oga-1        
1 hr     20 
3 hr     20 
5 hr     20 
12 hr     19 
24 hr     40 
        
Mitochondrial Dynamics       
Wildtype zdis5 (C. elegans N)     18 
ogt-1  (C. elegans N)     8 
oga-1  (C. elegans N)     12 
Wildtype zdis5 (mitochondria N)     259 
ogt-1  (mitochondria N)     159 
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